运动对肥胖儿童少年血管内皮功能与血清淀粉样蛋白A等炎症因子的影响
|
摘要
研究目的:中国的儿童少年肥胖发生率正逐年上升,肥胖严重危害其身心健康。肥胖者往往伴随着胰岛素抵抗、脂质代谢异常、慢性炎症及血管内皮功能障碍,血管内皮功能障碍的发生可能与上述因素有关。因此,本研究观察运动减肥前后肥胖儿童少年的脂质代谢、胰岛素抵抗、炎症水平及血管内皮功能的变化,探讨血管内皮功能与脂质代谢及系统炎症之间的相关性。旨在进一步探讨A-SAA等炎症因子在血管内皮功能损伤过程中的作用及运动减肥影响血管内皮功能的可能机制。
研究方法:选取全封闭式运动减肥夏令营肥胖儿童少年37人。运动减肥前首先进行跑台递增负荷试验来确定运动减肥的合适强度,确定每位受试者合适的运动心率范围并制定个体化的运动处方。本研究结合健康知识教育、合理膳食、有氧运动及行为干预的综合干预手段进行减肥干预。测量运动减肥前后肥胖受试者的身体形态学指标(主要包括:身高、体重、腰围、臀围、胸围、皮褶厚度)、身体机能指标(包括血压、心率、肺活量)。测定运动减肥前后的血脂(HDL-C、LDL-C、TC、TG、ApoA、ApoB)、空腹血糖(GLU)、空腹血清胰岛素(FINS)、糖化血红蛋白(HbAlc)、血浆内皮素-1(ET-1)、血清一氧化氮(NO)、血清血管性假血友病因子(vWF)、血清可溶性细胞间黏附分子-1(SICAM-1)、血清纤溶蛋白激活物-1(PAI-1)、脂肪细胞因子(血清Adi、血清LEP、血清TNF-α、血清IL-6、血清A-SAA)的水平。分析炎症因子、血管内皮细胞因子与其他指标之间的相关性,运动减肥干预后上述指标的变化情况。
研究结果:(1)运动减肥后,肥胖儿童少年的体重平均下降6.57Kg,下降了8.7%(P<0.01);BMI在运动减肥后由29.09Kg/m2下降至26.43Kg/m2,下降了9.1%(P<0.01);上臂和肩胛下角皮褶厚度之和下降12.47mm,下降了22%,有非常显著性统计学意义;体脂百分比下降了16.5%(P<0.01);腰围下降12.8cm,下降了14%(P<0.01);臀围下降9.36cm,下降了9.38%(P<0.01);腰臀比从0.91下降至0.87,下降了4.4%(P<0.01)。运动减肥后,颈围、上臂紧张围、上臂放松围皆显著下降。
(2)运动减肥后,肥胖受试者的收缩压、舒张压均有非常显著性下降,血管弹性指数升高并有显著统计学意义,脉压下降但并无显著统计学意义,安静心率下降并有非常显著性统计学意义,肺活量增加并有显著统计学意义。
(3)运动减肥后,受试者的空腹血糖及空腹胰岛素水平显著性下降,胰岛素抵抗指数明显下降;糖化血红蛋白水平也下降,但是并无显著性统计学意义;总胆固醇、甘油三酯、低密度脂蛋白胆固醇、载脂蛋白B水平显著性下降;载脂蛋白A及高密度脂蛋白胆固醇显著性下降,但是高密度脂蛋白胆固醇与低密度脂蛋白胆固醇的比值发生非常显著性升高(P<0.01);运动减肥后,动脉粥样硬化指数显著下降(P<0.01)。
37例受试者中,总胆固醇和甘油三酯同时超过正常范围的有9例,单纯甘油三酯超过正常范围的有5例,单纯总胆固醇升高的有5例。运动干预后脂质代谢紊乱得到纠正。(4)运动减肥前男、女肥胖儿童少年LEP、Adi、A-SAA、TNF-α、LNSTNFR2、IL-6、WBC均无显著性差异。运动减肥后,男、女肥胖儿童少年的LEP、WBC水平均发生非常显著性下降(P<0.01),男、女肥胖儿童少年的Adi水平均升高并有非常显著性统计学意义,男性肥胖儿童少年的A-SAA及IL-6发生显著性下降(P<0.05),女性肥胖儿童少年的A-SAA及IL-6均发生非常显著性下降(P<0.01)。运动减肥前轻中度肥胖组与重度肥胖组相比,重度肥胖组的脂联素水平比轻中度肥胖组低27.13%(P<0.05);重度肥胖组的WBC及A-SAA水平比轻中度肥胖组分别高14.66%和23.87%(P<0.05)。运动减肥后,轻中度肥胖组LEP、IL-6水平有非常显著性下降(P<0.01),WBC下降28.85%(P<0.01),Adi水平升高16.28%(P<0.01),A-SAA下降了21.89%(P<0.05);重度肥胖组减肥后LEP、A-SAA、WBC均发生非常显著性下降,其中A-SAA下降了28.20%(P<0.01),Adi升高36.17%(P<0.01)。说明运动减肥后,体内炎症水平下降。血清Adi与腰围、BMI、AI、FINS、HOMA-IR呈负相关,与ISI、HDL、ApoA呈正相关。说明Adi与中心型肥胖有关,且随着肥胖程度的加重Adi水平下降,Adi水平下降会导致动脉硬化指数及胰岛素抵抗程度的加重,从而增加动脉粥样硬化发生的风险。LEP水平与脂肪量呈正相关,说明脂肪含量越高,瘦素水平越高,这是体内一种反馈调节的表现。
(5)运动减肥后,轻中度及重度肥胖组受试者的血清NO的水平均升高(P<0.01),分别比运动减肥前升高70.75%和101.1%;血浆ET-1水平下降,亦有显著性统计学意义。说明运动减肥后血管内皮的舒缩功能得到改善。减肥前,轻中度与重度肥胖受试者的血浆vWF、血清SICAM-1、血清PAI-1、血小板计数均无显著性差异。运动减肥后,不同肥胖程度的两组受试者的血浆vWF分别下降55.88%(P<0.01)和48.94%(P<0.01);血清SICAM-1分别下降17.51%(P<0.01)和17.15%(P<0.01);血清PAI-1分别下降21.81%(P<0.05)和26.69%(P<0.01);红细胞压积分别下降5.78%(P<0.01)和4.96%(P<0.01);血小板计数分别下降22.84%(P<0.05)和24.95%(P<0.01)。以上数据说明,减肥后肥胖少年儿童的内皮凝血、黏附、纤溶功能发生显著性改善。相关性分析表明,ET-1与炎症因子TNF-α、IL-6呈显著正相关。血清NO的含量与舒张压、皮褶厚度呈显著负相关。血浆vWF与甘油三酯、血糖的对数呈正相关;SICAM-1与LEP呈正相关;PAI-1与WBC、TNF-α、IL-6、ET-1呈显著正相关。
研究结论:(1)全封闭式运动减肥显著改善了肥胖受试者的身体形态、糖脂代谢紊乱及胰岛素的敏感性。(2)全封闭式运动减肥可以显著提高脂联素水平,降低瘦素的水平,有效降低肥胖受试者体内的炎症状态。提示有氧运动可能通过降低炎症标志物的水平及升高脂联素水平发挥抗炎作用,从而防止动脉粥样硬化等疾病的发生和发展。(3)血管内皮功能障碍与炎症状态有关,全封闭式运动减肥有效改善了肥胖受试者血管内皮舒缩、凝血、粘附及纤溶功能。提示运动减肥是下调炎症因子和缓解内皮功能障碍的有效手段,对于预防AS、MS等疾病的发生具有重要意义。
Objective: Data shows that obesity incidence is rising year by year in China, which seriously damaged their physical and mental health. As we all know, obesity often accompanies with insulin resistance, lipid metabolic abnormalities, chronic inflammation and endothelial dysfunction, and endothelial dysfunction has some relations with the diseases above. Therefore, this study observed obese children and adolescents’blood lipid metabolism, inflammatory factors, vascular endothelial function before and after 4 weeks’aerobic exercise, explored the correlation between endothelial function and other indicators, discussed the changes of proinflammatory A-SAA after weight loss and the relationship between proinflammatory such as A-SAA and endothelial function, in order to further explore the role of proinflammatory factor A-SAA in endothelial function damage and the possible mechanisms of weight loss to endothelial function.
Methods: 37 obese children and adolescents were selected from the fully closed weight camp as subjects. Before starting the exercise programme, subjects underwent a graded treadmill stress test to determine the appropriate individual level of exercise intensity. On the basis of the results, the subjects were provided with an appropriate training heart rate and given an individualized weight loss programme. The subjects were intervened with methods of health knowledge education, reasonable diet, aerobic exercise and behavior intervention. Before and after 4 weeks intervention, body morphology index (mainly includes: height, weight, waist circumference, hip circumference, chest circumference and skin-fold), body function index (including the blood pressure and heart rate, vital capacity) were measured. The blood lipid (HDL-C、LDL-C、TC、TG、ApoA、ApoB), fasting blood-glucose(FBG), fasting insulin(FINS), glycated hemoglobin, plasma endothelin-1, serum nitric oxide, serum vWF, serum soluble intercellular adhesion molecule-1, serum PAI-1, Adipocytokines(serum adiponectin, blood leptin, serum tumor necrosis factor alpha, serum IL-6, A-SAA) were also measured before and after the weight loss programme.
The changes of vascular endothelial vasomotion, clotting, adhesion, fibrinolytic functions were analyzed after 4 weeks. Before and after weight loss, proinflammatory factors were analyzed, and the correlations between A-SAA and blood sugar, blood lipid and inflammatory factors were discussed. The results: (1) After weight loss intervention, the subjects’body weight dropped 6.57 kilogrammes, dropped 8.7% (P < 0.01); BMI dropped from 29.09 Kg/m2 to 26.43Kg/m~2, dropped 9.1%(P<0.01); the sum of upper arm and shoulder Angle skin-fold dropped 12.47 mm, dropped 22%(P<0.01); Body fat percentage dropped 16.5% (P < 0.01), Waist circumference declined 12.8 cm, declined 14% (P < 0.01), Hip circumference declined 9.36 cm, dropped 9.38% (P < 0.01), Waist-hip ratio dropped from 0.91 to 0.87, dropped 4.4% (P < 0.01). After the weight loss programme, neck circumference, upper arm tension circumference, upper arm relax circumference all dropped significantly.
(2) After weight loss programme, obese subjects’systolic blood pressure and diastolic blood pressure declined very significally, vessel elasticity index rised and had statistical significance, pulse pressure dropped but had no statistical significance, resting heart rate dropped and had very significant statistical significance, vital capacity increased and had significant statistical significance.
(3) After weight loss programme, subjects’fasting glucose and fasting insulin levels decreased significantly, insulin resistance index declined obviously, glycated hemoglobin levels also declined, but there were no significant statistical significance, total cholesterol, triglyceride and low density lipoprotein cholesterol, apolipoprotein B decreased significantly; Apolipoprotein A and high-density lipoprotein cholesterol decreased significantly, but HDL and LDL ratio increased very significantly (P < 0.01), Atherosclerosis index dropped significantly (P < 0.01). Among 37 subjects, there were 9 subjects whose total cholesterol and triglyceride beyond the normal range, 5 subjects whose triglyceride and 5 subjects whose cholesterol beyond the normal range. After weight loss programme, blood lipid returned to the normal range.
(4) Before weight loss programme, there were no significant differences in the levels of leptin, adiponectin, A-SAA, tumor necrosis factor alpha, LNSTNFR2, IL-6, WBC between female and male subjects. After weight intervention, the level of leptin and WBC declined very significantly, adiponectin increased very significantly in male and female subjects (P<0.01). Serum A-SAA and IL-6 reduced significantly in male subjects (P<0.05), while very significantly in female subjects (P<0.01). Before weight loss,mild-to-moderate obesity group and group compared , adiponectin of severe obese group was lower 27.13% (P<0.05) than that of mild-to-moderate obesity group, WBC and A-SAA levels were higher 14.66% and 23.87% respectively(P<0.05). After weight loss intervention, leptin, IL-6 levels declined very significantly (P<0.01), leukocyte declined 28.85% (P<0.01), adiponectin levels increased 16.28% (P<0.01), A-SAA dropped 21.89% (P<0.05) in mild-to-moderate obesity group; leptin, A-SAA, WBC declined very significantly, A-SAA dropped 28.20% (P<0.01), adiponectin increased 36.17% in severely obese group (P<0.01). It showed that inflammation level decreased after weight loss. Serum adiponectin was correlated with waist circumference, body mass index (BMI), AI, INS, HOMA-IR negatively, correlated with ISI, HDL, ApoA positively, which shows that adiponectin had some relations with abdominal obesity and reduced with obesity. The drop of adiponectin levels would cause atherosclerosis index increasing and insulin resistance level aggravating, which would increase the risk of atherosclerosis. We also found that Leptin level was positively correlated with the fat mass. It told us that more fat mass, higher leptin, which might be the body feedback adjustment performance.
(5) After 4 weeks' weight loss programme, in mild-to-moderate and severely obese group, serum levels of nitric oxide increased significantly (P<0.01), elevated 70.75% and 101.1% respectively compared with the level before weight loss; Plasma endothelin levels droped significantly, which showed that after weight loss the vasomotion vascular endothelial function improved. Before weight loss, plasma vWF, serum SICAM-1, serum PAI-1, platelet count of mild-to-moderate and severe obese participants exited no significant differences. Severe obese participants' HCT were higher 5.22% than that of mild-to-moderate obesity group (P<0.05). After weight loss, plasma vWF dropped 55.85% (P<0.01) and 48.94% (P<0.01)respectively, Serum SICAM-1 dropped 17.51%(P<0.01) and 17.15% (P<0.01) respectively, Serum PAI-1 dropped 21.81% (P<0.01) and 26.69% (P<0.01) respectively, HCT dropped 5.78%(P<0.01) and 4.96%(P<0.01) respectively, Platelet count dropped 22.84% (P<0.05) and 24.95% (P<0.01) respectively in the two groups. Datas above showed that after weight loss, endothelial clotting, adhesion, fibrinolytic function significantly improved. Correlation analysis showed that, ET-1 positively correlated with TNF alpha, IL-6. Serum levels of nitric oxide correlated negatively with diastolic blood pressure, skin-fold. Plasma vWF positively correlated with triglyceride, lNGLU; SICAM-1 correlated positively with LEP, PAI-1 correlated with WBC and TNF alpha, IL-6, ET-1 significantly.
Conclusion: (1) Aerobic exercise significantly improved obese subjects’body shape, glucolipid metabolism disorders and insulin sensitivity. (2) Aerobic exercise significantly enhanced the level of adiponectin, reduced the level of serum leptin and inflammatory factors of the obesity in fully closed weight camp.It told us that aerobic exercise played an important role in reducing inflammatory factors’level, preventing occurrence and development of atherosclerosis. (3) Vascular endothelial dysfunction has close relationship with inflammation. Aerobic exercise improved obese subjects’vascular endothelial vasomotion, clotting, adhesion and fibrinolytic function, which showed that aerobic exercise was an effective means in reducing inflammation level and recovering endothelial dysfunction to prevent from diseases such atherosclerosis and metabolic syndrome.
研究方法:选取全封闭式运动减肥夏令营肥胖儿童少年37人。运动减肥前首先进行跑台递增负荷试验来确定运动减肥的合适强度,确定每位受试者合适的运动心率范围并制定个体化的运动处方。本研究结合健康知识教育、合理膳食、有氧运动及行为干预的综合干预手段进行减肥干预。测量运动减肥前后肥胖受试者的身体形态学指标(主要包括:身高、体重、腰围、臀围、胸围、皮褶厚度)、身体机能指标(包括血压、心率、肺活量)。测定运动减肥前后的血脂(HDL-C、LDL-C、TC、TG、ApoA、ApoB)、空腹血糖(GLU)、空腹血清胰岛素(FINS)、糖化血红蛋白(HbAlc)、血浆内皮素-1(ET-1)、血清一氧化氮(NO)、血清血管性假血友病因子(vWF)、血清可溶性细胞间黏附分子-1(SICAM-1)、血清纤溶蛋白激活物-1(PAI-1)、脂肪细胞因子(血清Adi、血清LEP、血清TNF-α、血清IL-6、血清A-SAA)的水平。分析炎症因子、血管内皮细胞因子与其他指标之间的相关性,运动减肥干预后上述指标的变化情况。
研究结果:(1)运动减肥后,肥胖儿童少年的体重平均下降6.57Kg,下降了8.7%(P<0.01);BMI在运动减肥后由29.09Kg/m2下降至26.43Kg/m2,下降了9.1%(P<0.01);上臂和肩胛下角皮褶厚度之和下降12.47mm,下降了22%,有非常显著性统计学意义;体脂百分比下降了16.5%(P<0.01);腰围下降12.8cm,下降了14%(P<0.01);臀围下降9.36cm,下降了9.38%(P<0.01);腰臀比从0.91下降至0.87,下降了4.4%(P<0.01)。运动减肥后,颈围、上臂紧张围、上臂放松围皆显著下降。
(2)运动减肥后,肥胖受试者的收缩压、舒张压均有非常显著性下降,血管弹性指数升高并有显著统计学意义,脉压下降但并无显著统计学意义,安静心率下降并有非常显著性统计学意义,肺活量增加并有显著统计学意义。
(3)运动减肥后,受试者的空腹血糖及空腹胰岛素水平显著性下降,胰岛素抵抗指数明显下降;糖化血红蛋白水平也下降,但是并无显著性统计学意义;总胆固醇、甘油三酯、低密度脂蛋白胆固醇、载脂蛋白B水平显著性下降;载脂蛋白A及高密度脂蛋白胆固醇显著性下降,但是高密度脂蛋白胆固醇与低密度脂蛋白胆固醇的比值发生非常显著性升高(P<0.01);运动减肥后,动脉粥样硬化指数显著下降(P<0.01)。
37例受试者中,总胆固醇和甘油三酯同时超过正常范围的有9例,单纯甘油三酯超过正常范围的有5例,单纯总胆固醇升高的有5例。运动干预后脂质代谢紊乱得到纠正。(4)运动减肥前男、女肥胖儿童少年LEP、Adi、A-SAA、TNF-α、LNSTNFR2、IL-6、WBC均无显著性差异。运动减肥后,男、女肥胖儿童少年的LEP、WBC水平均发生非常显著性下降(P<0.01),男、女肥胖儿童少年的Adi水平均升高并有非常显著性统计学意义,男性肥胖儿童少年的A-SAA及IL-6发生显著性下降(P<0.05),女性肥胖儿童少年的A-SAA及IL-6均发生非常显著性下降(P<0.01)。运动减肥前轻中度肥胖组与重度肥胖组相比,重度肥胖组的脂联素水平比轻中度肥胖组低27.13%(P<0.05);重度肥胖组的WBC及A-SAA水平比轻中度肥胖组分别高14.66%和23.87%(P<0.05)。运动减肥后,轻中度肥胖组LEP、IL-6水平有非常显著性下降(P<0.01),WBC下降28.85%(P<0.01),Adi水平升高16.28%(P<0.01),A-SAA下降了21.89%(P<0.05);重度肥胖组减肥后LEP、A-SAA、WBC均发生非常显著性下降,其中A-SAA下降了28.20%(P<0.01),Adi升高36.17%(P<0.01)。说明运动减肥后,体内炎症水平下降。血清Adi与腰围、BMI、AI、FINS、HOMA-IR呈负相关,与ISI、HDL、ApoA呈正相关。说明Adi与中心型肥胖有关,且随着肥胖程度的加重Adi水平下降,Adi水平下降会导致动脉硬化指数及胰岛素抵抗程度的加重,从而增加动脉粥样硬化发生的风险。LEP水平与脂肪量呈正相关,说明脂肪含量越高,瘦素水平越高,这是体内一种反馈调节的表现。
(5)运动减肥后,轻中度及重度肥胖组受试者的血清NO的水平均升高(P<0.01),分别比运动减肥前升高70.75%和101.1%;血浆ET-1水平下降,亦有显著性统计学意义。说明运动减肥后血管内皮的舒缩功能得到改善。减肥前,轻中度与重度肥胖受试者的血浆vWF、血清SICAM-1、血清PAI-1、血小板计数均无显著性差异。运动减肥后,不同肥胖程度的两组受试者的血浆vWF分别下降55.88%(P<0.01)和48.94%(P<0.01);血清SICAM-1分别下降17.51%(P<0.01)和17.15%(P<0.01);血清PAI-1分别下降21.81%(P<0.05)和26.69%(P<0.01);红细胞压积分别下降5.78%(P<0.01)和4.96%(P<0.01);血小板计数分别下降22.84%(P<0.05)和24.95%(P<0.01)。以上数据说明,减肥后肥胖少年儿童的内皮凝血、黏附、纤溶功能发生显著性改善。相关性分析表明,ET-1与炎症因子TNF-α、IL-6呈显著正相关。血清NO的含量与舒张压、皮褶厚度呈显著负相关。血浆vWF与甘油三酯、血糖的对数呈正相关;SICAM-1与LEP呈正相关;PAI-1与WBC、TNF-α、IL-6、ET-1呈显著正相关。
研究结论:(1)全封闭式运动减肥显著改善了肥胖受试者的身体形态、糖脂代谢紊乱及胰岛素的敏感性。(2)全封闭式运动减肥可以显著提高脂联素水平,降低瘦素的水平,有效降低肥胖受试者体内的炎症状态。提示有氧运动可能通过降低炎症标志物的水平及升高脂联素水平发挥抗炎作用,从而防止动脉粥样硬化等疾病的发生和发展。(3)血管内皮功能障碍与炎症状态有关,全封闭式运动减肥有效改善了肥胖受试者血管内皮舒缩、凝血、粘附及纤溶功能。提示运动减肥是下调炎症因子和缓解内皮功能障碍的有效手段,对于预防AS、MS等疾病的发生具有重要意义。
Objective: Data shows that obesity incidence is rising year by year in China, which seriously damaged their physical and mental health. As we all know, obesity often accompanies with insulin resistance, lipid metabolic abnormalities, chronic inflammation and endothelial dysfunction, and endothelial dysfunction has some relations with the diseases above. Therefore, this study observed obese children and adolescents’blood lipid metabolism, inflammatory factors, vascular endothelial function before and after 4 weeks’aerobic exercise, explored the correlation between endothelial function and other indicators, discussed the changes of proinflammatory A-SAA after weight loss and the relationship between proinflammatory such as A-SAA and endothelial function, in order to further explore the role of proinflammatory factor A-SAA in endothelial function damage and the possible mechanisms of weight loss to endothelial function.
Methods: 37 obese children and adolescents were selected from the fully closed weight camp as subjects. Before starting the exercise programme, subjects underwent a graded treadmill stress test to determine the appropriate individual level of exercise intensity. On the basis of the results, the subjects were provided with an appropriate training heart rate and given an individualized weight loss programme. The subjects were intervened with methods of health knowledge education, reasonable diet, aerobic exercise and behavior intervention. Before and after 4 weeks intervention, body morphology index (mainly includes: height, weight, waist circumference, hip circumference, chest circumference and skin-fold), body function index (including the blood pressure and heart rate, vital capacity) were measured. The blood lipid (HDL-C、LDL-C、TC、TG、ApoA、ApoB), fasting blood-glucose(FBG), fasting insulin(FINS), glycated hemoglobin, plasma endothelin-1, serum nitric oxide, serum vWF, serum soluble intercellular adhesion molecule-1, serum PAI-1, Adipocytokines(serum adiponectin, blood leptin, serum tumor necrosis factor alpha, serum IL-6, A-SAA) were also measured before and after the weight loss programme.
The changes of vascular endothelial vasomotion, clotting, adhesion, fibrinolytic functions were analyzed after 4 weeks. Before and after weight loss, proinflammatory factors were analyzed, and the correlations between A-SAA and blood sugar, blood lipid and inflammatory factors were discussed. The results: (1) After weight loss intervention, the subjects’body weight dropped 6.57 kilogrammes, dropped 8.7% (P < 0.01); BMI dropped from 29.09 Kg/m2 to 26.43Kg/m~2, dropped 9.1%(P<0.01); the sum of upper arm and shoulder Angle skin-fold dropped 12.47 mm, dropped 22%(P<0.01); Body fat percentage dropped 16.5% (P < 0.01), Waist circumference declined 12.8 cm, declined 14% (P < 0.01), Hip circumference declined 9.36 cm, dropped 9.38% (P < 0.01), Waist-hip ratio dropped from 0.91 to 0.87, dropped 4.4% (P < 0.01). After the weight loss programme, neck circumference, upper arm tension circumference, upper arm relax circumference all dropped significantly.
(2) After weight loss programme, obese subjects’systolic blood pressure and diastolic blood pressure declined very significally, vessel elasticity index rised and had statistical significance, pulse pressure dropped but had no statistical significance, resting heart rate dropped and had very significant statistical significance, vital capacity increased and had significant statistical significance.
(3) After weight loss programme, subjects’fasting glucose and fasting insulin levels decreased significantly, insulin resistance index declined obviously, glycated hemoglobin levels also declined, but there were no significant statistical significance, total cholesterol, triglyceride and low density lipoprotein cholesterol, apolipoprotein B decreased significantly; Apolipoprotein A and high-density lipoprotein cholesterol decreased significantly, but HDL and LDL ratio increased very significantly (P < 0.01), Atherosclerosis index dropped significantly (P < 0.01). Among 37 subjects, there were 9 subjects whose total cholesterol and triglyceride beyond the normal range, 5 subjects whose triglyceride and 5 subjects whose cholesterol beyond the normal range. After weight loss programme, blood lipid returned to the normal range.
(4) Before weight loss programme, there were no significant differences in the levels of leptin, adiponectin, A-SAA, tumor necrosis factor alpha, LNSTNFR2, IL-6, WBC between female and male subjects. After weight intervention, the level of leptin and WBC declined very significantly, adiponectin increased very significantly in male and female subjects (P<0.01). Serum A-SAA and IL-6 reduced significantly in male subjects (P<0.05), while very significantly in female subjects (P<0.01). Before weight loss,mild-to-moderate obesity group and group compared , adiponectin of severe obese group was lower 27.13% (P<0.05) than that of mild-to-moderate obesity group, WBC and A-SAA levels were higher 14.66% and 23.87% respectively(P<0.05). After weight loss intervention, leptin, IL-6 levels declined very significantly (P<0.01), leukocyte declined 28.85% (P<0.01), adiponectin levels increased 16.28% (P<0.01), A-SAA dropped 21.89% (P<0.05) in mild-to-moderate obesity group; leptin, A-SAA, WBC declined very significantly, A-SAA dropped 28.20% (P<0.01), adiponectin increased 36.17% in severely obese group (P<0.01). It showed that inflammation level decreased after weight loss. Serum adiponectin was correlated with waist circumference, body mass index (BMI), AI, INS, HOMA-IR negatively, correlated with ISI, HDL, ApoA positively, which shows that adiponectin had some relations with abdominal obesity and reduced with obesity. The drop of adiponectin levels would cause atherosclerosis index increasing and insulin resistance level aggravating, which would increase the risk of atherosclerosis. We also found that Leptin level was positively correlated with the fat mass. It told us that more fat mass, higher leptin, which might be the body feedback adjustment performance.
(5) After 4 weeks' weight loss programme, in mild-to-moderate and severely obese group, serum levels of nitric oxide increased significantly (P<0.01), elevated 70.75% and 101.1% respectively compared with the level before weight loss; Plasma endothelin levels droped significantly, which showed that after weight loss the vasomotion vascular endothelial function improved. Before weight loss, plasma vWF, serum SICAM-1, serum PAI-1, platelet count of mild-to-moderate and severe obese participants exited no significant differences. Severe obese participants' HCT were higher 5.22% than that of mild-to-moderate obesity group (P<0.05). After weight loss, plasma vWF dropped 55.85% (P<0.01) and 48.94% (P<0.01)respectively, Serum SICAM-1 dropped 17.51%(P<0.01) and 17.15% (P<0.01) respectively, Serum PAI-1 dropped 21.81% (P<0.01) and 26.69% (P<0.01) respectively, HCT dropped 5.78%(P<0.01) and 4.96%(P<0.01) respectively, Platelet count dropped 22.84% (P<0.05) and 24.95% (P<0.01) respectively in the two groups. Datas above showed that after weight loss, endothelial clotting, adhesion, fibrinolytic function significantly improved. Correlation analysis showed that, ET-1 positively correlated with TNF alpha, IL-6. Serum levels of nitric oxide correlated negatively with diastolic blood pressure, skin-fold. Plasma vWF positively correlated with triglyceride, lNGLU; SICAM-1 correlated positively with LEP, PAI-1 correlated with WBC and TNF alpha, IL-6, ET-1 significantly.
Conclusion: (1) Aerobic exercise significantly improved obese subjects’body shape, glucolipid metabolism disorders and insulin sensitivity. (2) Aerobic exercise significantly enhanced the level of adiponectin, reduced the level of serum leptin and inflammatory factors of the obesity in fully closed weight camp.It told us that aerobic exercise played an important role in reducing inflammatory factors’level, preventing occurrence and development of atherosclerosis. (3) Vascular endothelial dysfunction has close relationship with inflammation. Aerobic exercise improved obese subjects’vascular endothelial vasomotion, clotting, adhesion and fibrinolytic function, which showed that aerobic exercise was an effective means in reducing inflammation level and recovering endothelial dysfunction to prevent from diseases such atherosclerosis and metabolic syndrome.
引文
[1]黄岚.血管损伤性疾病—从分子到临床[M].人民卫生出版社, 2008:26.
[2]Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases [J]. Diabetes Metab Res Rev, 2006, 22(6): 423-436.
[3]Asako M, Seiji M, Mutsuko Y, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men[J]. Angiology, 2009, 60(3): 351-357.
[4]Makimattila S, Yki-Jarvinen H. Endothelial dysfunction in human diabetes[J].Curr Diab Rep 2002, 2(1): 26-36.
[5]Chobanian AV, Bakris GL, Black HR, et al.The seventh report of the joint national committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: the JNC 7 Report[J]. JAMA, 2003, 289(19): 2560-2572.
[6] Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance[J]. Circulation, 2000, 101(15): 1780-1784.
[7]王钢.冠心病血管内皮功能障碍的评价[J].锦州医学院学报, 2005, 26(2): 56. [ 8 ]赵玉英,智光.评价血管内皮功能的方法[J].中华老年心脑血管病杂志,2004, 16(3):208-210.
[9] Vincent MA, Barrett EJ, Lindner JR, et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin[J]. Am J Physiol Endocrinol Metab, 2003, 285(1): E123-E129.
[10]Kuvin JT, Karas RH. Clinical utility of endothelial function testing: ready for prime time? [J]. Circulation, 2003, 107(25): 3243-3247.
[11]Meyer AA, Kundt G, Lenschow U, et al. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program [J]. J Am Coll Cardiol, 2006, 48(9): 1865-1870.
[12]Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force [J]. J Am Coll Cardiol, 2000, 39(2): 257-265.
[13] Eskurza I, Seals DR, DeSouza DA, et al. Pharmacological vs flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans[J]. Am J Cardiol, 2001, 88(9): 1067-1069.
[14]Spranger J, Kroke A, Mohlig M, et al. Infammatory cytokines and the risk to develop type 2 diabetes, results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study[J]. Diabetes, 2003, 52(3): 812-817.
[15]Pradham AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin-6 and the risk of developing type 2 diabetes mellitus[J]. JAMA , 2001, 286(3): 327-334.
[16]Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from humanendothelial cells and modulates its circulating levels in vivo[J]. J Clin Endocrinol Metab, 1995, 80(3): 829-835.
[17]Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation[J]. Nat Rev Immunol, 2007, 7(10): 803–815.
[18]Schwartz CJ, Valente AJ, Sprague EA. A modern view of atheroselerosis[J]. Am J Cardiol, 1993, 71(6): 9B-14B.
[19]Ludmer P, Selwyn A, Shook T, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries[J]. N Engl J Med, 1986, 315(17): 1046-1051.
[20]Van Guilder GP, Stauffer BL, Greiner JJ, et al. Impaired endothelium-dependent vasodilation in overweight and obese adults humans is not limited to muscarinic receptor agonist[J]. Am J Physiol Heart Circ Physiol, 2008, 294(4): H1685-H1692.
[21]Brook RD, Bard RL, Rubenfire M, et al. Usefulness of visceral obesity(waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults[J]. Am J Cardiol, 2001, 88(11): 1264-1269. [ 22 ]Moncada S, Palmer RM, Higgs EA. Nitricoxide: physiology, pathophysiology, and pharmacology [J]. Pharmacol Rev, 1991, 43(2): 102-142.
[23]Oflaz H, Ozbey N, Mantar F, et al. Determination of endothelial function and early atherosclerotic changes in healthy obese woman [J]. Diabetes Nutr Metab, 2003, 16(3): 176-181.
[24]陈瑶,汪翼,李燕等.不同干预方法对实验性肥胖大鼠早期血管内皮功能障碍作用的比较[J].中华儿科杂志, 2006, 44(8): 607-610.
[25]朱旅云.超重和肥胖对血管内皮功能的影响[J].中华心血管病杂志, 2001, 29(12): 750-752.
[26]彭向峰.单纯性肥胖少儿血内皮素、血脂的改变及耐力运动对其影响的研究[J].中国运动医学杂志, 2000, 19(2): 167-173.
[27]Nofer JR, Toll M, Ciet M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor SIP3 [J]. J Clin Invest, 2004, 113(4): 569-581.
[28]Esposito K, Marfalla R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome:a randomized trial [J]. JAMA, 2004, 292(12): 1440-1446.
[29]Valle Jiménez M, Estepa RM, Camacho RM, et al. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children [J]. Eur J Endocrinol, 2007, 156 (4): 497-502.
[30]Hilberg T, Nowacki PE, Muller-berghaus G, et al. Changes in blood coagulation and fibtinolyais associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives [J]. J Sci Med Sport, 2000, 3(4): 83-90.
[31]Rohde LE, Lee RT, Rivero J, et al. Circulating cell adhesion molecules correlate with ultrasound-based assessment of carotid atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 1998, 18(11): 1765-1770.
[32]Shai I, Pischon T, Hu FB, Ascherio A, et al. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease [J]. Obesity, 2006, 14(11): 2099-2106.
[33]Vanderwall AC, Das PK, Tigges AJ, et al. Adhension molecules on the endothelium and mononuclear cells in human atherosclerotic lesions [J]. Pathol, 1992, 141(6): 1427-1433.
[34]Valle Jiménez M, Estepa RM, Camacho RM, et al. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children[J]. Eur J Endocrinol, 2007, 156 (4): 497-502.
[35]Buchwalter G, Gross C, Wasylyk B, et al. The ternary Complex factor Net regulates cell migration through migration through inhibition of PAI-1 expression [J]. Mol Cell Biol, 2005, 25(24): 10853-10862.
[36]Bastelica D, Morange P, Bert het B, et al. Stromal cells are the main plasminogen activat or inhibit or producing cells in human fat:evidence of differences between visceral and subcutaneous deposits [J]. Arterioscler Thromb Vasc Biol, 2002, 22 (1): 173-178.
[37]Solano M P, Perry A C, Wang X, et al. Insulin resistance but not visceral adipose tissue is associated with plasminogen activat or inhibit or type 1 levels in overweight and obese p remenopausal African-American women [J]. Int J Obes Relat Metab Disord, 2003, 27(1): 82-87.
[38]Glowinska B, Urban M, Koput A, et al. Selected new at herosclerosis risk f act ors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes [J]. Przegl Lek, 2000, 60 (1): 12-17.
[39] Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system [J]. Obes Rev, 2002, 3 (2): 85-101.
[40]王宁,喻书彻,王瑛等.儿童单纯性肥胖症凝血、纤溶指标的测定及其意义[J].中国儿童保健杂志, 2000, 8(5): 302-304. [ 41 ]Salomaa V, Stinson V, Kark JD. Association of fibrionlytic parameters with early atherosclerosis the ARIC study atherosclerosis risk in communities study [J]. Circulation, 1995, 91(2): 284-290.
[42]Cigolini M, Targher G, Bergamo Andreis IA, et al. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men [J]. Arterioscler Thromb Vacs Biol, 1996, 16(3): 368-370.
[43]Mlahm EN, Cauley JA, Tracy RP, et al. Association of sex hormones and adiposiry with plasma concentrations of fibrinogen and PAI-1 in postmenopausal women [J]. AM J Epidemiol, 1996, 143(2): 159-162.
[44]Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases:the role of oxidant stress [J]. Circ Res, 2000, 87: 840-844.
[45]Erdei N, Toth A, Pasztor ET, et al. High-fat diet-induced reduction in nitricoxide-dependent arteriolar dilation in rats:role of xanthine oxidase-derived superoxide anion [J]. Am J Physiol Heart Circ Physiol, 2006, 291(5): H2107–H2115.
[46]ZHU LY, LIU KS. Study of insulin resistance and insulin secretion function in overweight and obese subjects with endothelial dysfunction[J]. China Journal of Modern Medicine, 2004, 14(14): 27-30.
[47]Nigro J, Osman N, Dart AM, et al. Insulin resistance and atherosclerosis [J]. Endocr Rev, 2006, 27(3): 242-259.
[48]Gomez Rosso L, Benitez MB, Fornari MC, et al. Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome [J]. At herosclerosis, 2008, 1999(2): 415-423.
[49]Amar J, Perez L, Burcclin R, et al. Arteries, inflammation and insulin resistance [J]. J Hypertens Suppl, 2006, 24(5): S18-20.
[50]Fay WP. Plasminogen activator inhibitor-1, fibrin, and the vascular response to injury [J].Trends Cardiovasc Med, 2004, 14(5): 196-202.
[51]Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes[J]. Science, 2005, 307 (5708): 384-387.
[52]Kershaw EE, Flier JS. Adipose tissue as an endocrine organ[J]. J Clin endocrinol Metab, 2004, 89(6): 2548-2556.
[53]Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of Plasma Protein encoded by the obese gene [J]. Science, 1995, 269(5223): 543-546.
[54] Bouloumie A, Marumo T, Lafontan M, et al. Leptin induces oxidative stress in human endothelial cells [J]. FASEB J, 1999, 13(10): 1231-1238.
[55]Kang SM, Kwon HM, Hong BK, et al. Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization [J].Yonsei Med J, 2000, 41(1): 68-75.
[56]Vecchione C, Aretini A, Maffei A, et al. Cooperation between insulin and leptinin the modulation of vascular tone [J]. Hypertension, 2003, 42(2): 166-170.
[57]Quehenberger P, Exner M, Sunder R, et al. Leptin induces endothelin-1 in endothelial cells in vitro [J]. Cire Res, 2002, 90 (6): 711-718.
[58]De Mitrio V, De Pergola G, Vettor R, et al. Plasma plasminogen activator inhibitorl is associated with plasma with lepin irrespetive of body mass index, bodv fat mauss and plasma insulian and metabolic parameters in premenopausal women [J]. Metabolism, 1999, 48(8): 960-964.
[59]Rahmouni K, Morgan DA, Morgan GM, et al. Role of selective leptin resistance in diet-induced obesity hypertension [J]. Diabetes, 2005, 54(7): 2012-2018.
[60]Chen K, Li F, Li J, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin [J]. Nat Med, 2006, 12(4): 425–432.
[61] Park HY, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro [J]. Exp Mol Med, 2001, 33(2): 95-102.
[62]Kang SM, Kwon HM,Hong BK, et al. Expression of leptin receptor in human atherosclerotic lesion:potential role in intimal neovascularization [J]. Yonsei Med J, 2000, 41(1): 68-75.
[63]Wolf G, Hamann A, Ham DC, et al. Leptin stimulates proliferation and TGF-βexpression in renal glomerular endothelial cells: potential role in gromerulosclerosis [J]. Kidney Int, 1999, 56(3): 860-872.
[64]Ribatti D, Nico B, Belloni AS, et al. Aigiogenic activity in the chick embryo chofioallantoic membrane is in part mediated by endogenous fibroblast growth factor [J]. Int J Mol Med, 2001, 8(3): 265.
[65]Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells [J]. FASEB J, 1999, 13(10): 1231-1238.
[66]Yamagishi S, EdelStein D, Du X, et al. Leptin induces mitochondnial superoxide production and monoeyte chemoattractant protein-1 expression in aortic endothelial cells by increasing factory acid oxidation via protein kinase A [J]. J Biol Chem, 200l, 26(27): 25096-25100.
[67]Stefan N, Bunt JC, Salbe AP, et al. Plasma adiponectin concentrations in obese children: relationship with obesity and insulinemia [J]. J Clin Endocrinol Metab, 2002, 87(10): 4652-4656.
[68]Hara T, Fujiwara H, Shoji T, et al. Decreased plasma adiponectin levels in young obese males [J]. J Atheroscler Thromb, 2003, 10 (4): 234-238.
[69]Asayama K, Hayashibe H, Dobashi K, et al. Decrease in serum adiponectin level due to obesity and visceral f at accumulation in children [J]. Obes Res, 2003, 11(9): 1072 -1079.
[70]Ouchi N, Kihara S, Funahashi T, et al. Obesity adiponectin and vascular inflammatory disease [J]. Cur r Opin Lipidol, 2003, 14 (6): 561-566.
[71]Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities [J]. J Mol Med, 2002, 80(11): 696 -702.
[72]Chandran M, Phillips SA, Ciaraldi T, et al. Adiponectin: more than just another fat cell hormone [J]. Diabetes Care, 2003, 26(8): 2442-2450.
[73]Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome[J]. J Intern Med, 2005, 257(2): 167-175.
[74]Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia [J]. J Clin Endocrinol Metab, 2001, 86(5): 1930-1935.
[75]Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia[J]. Clin Endocrinol Metab, 2002, 87(6): 2764-2769. [ 76 ]Kojima S, Funahashi T, Sakamoto T, Miyamoto S, et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction [J]. Heart, 2003, 89(6): 667-672.
[77]Kumada M, Kihara S, Sumitsuji S, Kawamoto T, et al. Association of hypoadiponectinemia with coronary artery disease in men [J]. Arterioscler Thromb Vasc Biol, 2003, 23(1): 85-89.
[78]Kazumi T, Kawaguchi A, Sakai K, et al. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure [J]. Diabetes Care, 2002, 25(6): 971-976.
[79]Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obestiy,insulin resistance,and hypercytokinemia [J]. J Clin Endocrinol Metab, 2000, 85(3): 1151-1158. [ 80 ]Margolis KL, Manson JE, Greenland P, et al. Leuokocyte count as a predictor of cardiovascular events and mortality in postmenopausal women:the Women's Health Initiative Observational Study [J]. Arch Intern Med, 2005, 165(5): 500-508.
[81]Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year [J]. Circulation, 2002, 105(7): 804-809.
[82]Perticone F, CeravoloR, Candigliota M, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: Protective effect of vitamin C[J]. Diabetes, 2001, 50(1): 159-165.
[83]Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase [J]. J Clin Invest, 1995, 95(5): 2111-2119.
[84]Li G, Barrett EJ, Barrett MO, et al. Tumor Necrosis Factor-αinduces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway[J]. Endocrinology, 2007, 148(7): 3356-3363.
[85] Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J]. J Clin Endocrinol Metab, 2000, 85(9): 3338-3342.
[86]Vozarova B, Weyer C, Hanson K, et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion [J]. Obes Res, 2001, 9(7): 414-417.
[87]Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance[J]. Diabetologia, 2003, 46(12): 1594-1603.
[88]Albert CM, Ma J, Rifai N, et al. Prospective study of C-Reactive protein,homocysteine,and plasma lipid levels as predictors of sudden cardiac death[J].Circulation, 2002,105(22): 2595-2599.
[89]Fichtlscherer S. Elevated CRP levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J]. Circulation, 2000, 102(9): 1000-1006.
[90]Kang SM, Chung N, Kim JY, et al. Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary disease[J]. Echocardiography, 2002, 19(8): 661-667.
[91]Gillum R F. Association of serum Creactive protein and indices of body f at distribution and overweight in Mexican American children[J]. J Natl Med Assoc, 2003, 95(7): 545-552.
[92]Jarvisalo MJ, Harmoinen A, Hakanen M, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children[J]. Arterioscler Thromb Vasc Biol, 2002, 22(8): 1323-1328.
[93]Tomai F. C reactive p rotein and microvascular f unction [J]. Heart, 2004, 90 (7): 727-728.
[94]Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediat or in at herothrombosis [J]. Hypertension, 2004, 44 (1): 6-11.
[95]Hatanaka E, Monteagudo PT, Marrocos MS, et al. Interaction between serum amyloid A and leukocytes-a possible role in the progression of vascular complications in diabetes [J]. Immunol Lett, 2007, 108(2): 160-166.
[96]JOUSILAHTI P, SALOMAA V, RASIV, et al. The association of C-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease-baseline findings of the PAIS project [J]. Atherosclerosis, 2001, 156 (2): 451-456.
[97]Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, et al. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass[J].Obes Surg, 2006, 16(3), 262-269.
[98]Gómez-Ambrosi J, Azcona C, Pati?o-García A, et al. Serum Amyloid A concentration is increased in obese children and adolescents [J]. J Pediatr, 2008, 153 (1): 71-75.
[99]余舒杰,刘金来.血清淀粉样蛋白A与冠心病的相关性研究[J].岭南心血管病杂志, 2005,11(4):252-255.
[100]Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes[J]. Diabetes Care, 2008, 31(supplement 2): S297–S302.
[101]Yao X Q, Liu F K, Qi X P, et al. Expression of survivin in human gastric adenocarcinomas: correlation and apoptosis [J]. Chin J Surg, 2004, 42(3): 145-148.
[102]Bergholm R, Tiikkainen M, Vehkavaara S, et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes [J]. Diabetes Care, 2003, 26(6): 1667-1672.
[103]Fonseca VA. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus[J]. Am J Med, 2007, 120 (9 Supp l 2): 18-25.
[104] Bojunga J, Nowak D, Mitrou PS, et al. Antioxidative treatment prevents activation of death receptor and mitochondrion-dependent apoptosis in the hearts of diabetic rats [J]. Diabetologia, 2004, 47(12): 2072-2080.
[105]Sena CM, Nunes E, Louro T, et al. Endothelial dysfunction in type 2 diabetes: effect of antioxidants [J]. Rev Port Cardiol, 2007, 26 (6): 609-619.
[106]曹建华.辛伐他丁对冠心病患者CRP、vWF、NO及ET-1的影响[J].中国老年学杂志, 2010, 30(8): 1138-1139.
[107]Waldinai PF, Marcelo CB, Simone NS, et al. One-Month Therapy With Simvastatin Restores Endothelial Function in Hypercholesterolemic Children and Adolescents [J]. Pediatr Cardiol, 2007, 28(1): 8-13.
[108]Pe?a AS, Wiltshire E, Gent R, et al. Folic acid does not improve endothelial function in obese children and adolescents [J]. Diabetes Care, 2007, 30 (8): 2122-2127.
[109]Sasaki S, Higashi Y, Nakagawa K, et al. A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension [J]. Am J Hyperten, 2002, 15(4): 302-309.
[110]Nicoletti G, Gugliano G, Pontillo A, et al. Effect of a multidisciplinary program of weight reduction on endothelial function in obese women [J]. J Endocrinol Invest, 2003, 26 (3): RC5.
[111]朱旅云,胡丽叶,王广宇等.单纯性肥胖者减重效果与血管内皮功能和胰岛素抵抗的关系[J].现代预防医学, 2008, 35(19): 3843-3845.
[112]Tanriverdi H, Evrengul H, Tanriverdi S, et al. Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism[J]. Circ J, 2005, 69(9): 1105-1110.
[113]Maeda S, Miyauchi T, Kakiyama T, et al. Effects of exercise training of 8 weeks and det raining on plasma levels of endothelium-derived factors, endothelin-1 and nitricoxide, in healthy young humans [J]. Life Sci, 2001, 69(9): 1005-1016.
[114]Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome[J]. Arteroiscler Thromb Vasc Biol, 2000, 20(2): 551-555.
[115]Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease [J]. N Engl J Med, 2000, 342(7): 454-460.
[116]都健.运动对胰岛素抵抗大鼠内皮依赖性血管舒张功能干预效应的研究[J].中国糖尿病杂志, 2003, 11(4): 268-271.
[117]Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure [J]. Circulation, 1996, 93(2): 210-214.
[118]Schmidt A, Pleiner J, Bayerle-Eder M, et al. Regular physical exercise improves endothelial function in heart transplant recipients [J]. Clin Transplant, 2002, 16(2): 137-143.
[119]Goto C, Higashi Y, Kimura M, et al. Effect of Different Intensities of Exercise on Endothelium-Dependent Vasodilation in Humans [J]. Circulation, 2003, 108(5): 530-535.
[120] Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children [J]. Circulation, 2004, 109(16): 1981-1986.
[121]Moien-Afshari F, Ghosh S, Khazaei M, et al. Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice [J]. Diabetologia, 2008, 51(7): 1327-1337.
[122]Gielen S, Erbs S, Linke A, et al. Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion[J]. Am Heart J, 2003, 145(1): E3.
[1]Charles MA. Early nutrition and weight evolution in children[J]. Ann Endocrinol, 2005, 66 (2): 11-18.
[2]Lawlor DA, Smith GD. Early life determinants of adult blood pressure [J]. Curr Opin Mphrol Typertens, 2005, 14 (3): 259-264.
[3]Grievink L, Alberts JF, O'Niel J, et al. Waist circumference as a measurement of obesity in the Nehgerlands Antilles;associations with hypertension and diabetes mellitus [J]. Eur J Clin Nutr, 2004, 58(8): 1159-1165.
[4]Hagan RD, Upton SJ, Wong L, Whittam J. The effects of aerobic conditioning and/or calorie restriction in overweight men and women[J]. Med Sci Sports Exerc, 1986, 18(1): 87-94.
[5]National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report[J].Obes Res, 1998, (6 suppl 2): 51S–209S.
[6]Ross R, Dagnone D, ones PJH, et al. Eduction in obesity and related comorbid conditions after diet induced weight loss or exercise-induced weight loss in men [J]. Ann Intern Med, 2000, 133(2): 92-103.
[7]中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值适宜体重指数和腰围切点的研究[J].中华流行病学杂志, 2002, 23(1): 5-10.
[8]林华,王洪.有氧健身操对中老年女性BMI和WHR的影响[J].体育科学, 2000, 20(3): 63-65.
[9]郑澜,房美玉,周建社等.有氧运动与针刺穴位对大鼠腹部脂肪及各项指标影响的研究[J].中国体育科技, 2006, 42(2): 122-124.
[10]季钢,刘艺,陈晓丽等.对肥胖青少年血压计脑血流动力学变化的研究.首都体育学院学报, 2005, 17(2): 115-116.
[11]Peco-Anti? A.Hypertension in obese children and adolescents[J]. Srp Arh Celok Lek, 2009, 137 (1-2): 91-97.
[12]Torrance B, McGuire KA, Lewanczuk R, et al. Overweight, physical activity and high blood pressure in children: a review of the literature[J]. Vasc Health Risk Manag, 2007, 3 (1): 139-149.
[13]Lazarus R, Gore CJ, Booth M, et al. Effects of body composition and fat distribution on ventilatory function in adults [J]. Am J Clin Nutr, 1998, 68(1): 35-41.
[14]Zerah F, Harf A, Perlemuter L, et al. Effects of obesity on respiratory resistance [J]. Chest, 1993, 103(5): 1470-1476.
[15]Conway B, Rene A. Obesity as a disease no light weight matter[J]. Obes Rev, 2004, 5(3): 145-151.
[16]Biring MS, Lewis MI, Liu JT, et al. Pulmonary physiologic changes of morbid obesity [J]. Am J Med Sci, 1999, 318(5): 293-297.
[17]Pankow W, Podszus T, Gutheil T, et al. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity [J]. J Appl Physiol, 1998, 85(4): 1236-1243.
[18]Rubinstein I, Zamel N, DuBarry L, et al. Airflow limitation in morbidly obese, nonsmoking men[J]. Ann Intern Med, 1990, 112(11): 828-832.
[19]Nemet D, Wang P, Funahashi T, et al. Adipocytokines body composition and fitness in children [J]. Pediatr Res, 2003, 53(1): 148-152.
[20]Moon YS, Kim DH, Song DK. Serum tumor necrosis factor alpha levels and components of the metabolic syndrome in obese adolescents [J]. Metabolism, 2004, 53(7): 863-867.
[21]Jubber AS. Respiratory complications of obesity[J]. Int J Chin Pract, 2004, 58(6): 573-580.
[22]WEISS R, CAPRIO S.The metabolic consequences of childhood obesity[J]. Best Pract Res Clin Endocrinol Metab, 2005, 19(3): 405-419.
[23]许逢明,黄宇戈,温杨祥,等.单纯性肥胖儿童血脂水平与血管内皮功能的相关性研究[J].中国妇幼保健, 2005, 20(11): 1361-1363.
[24]中国医师协会儿童健康委员会,中华心血管病协会动脉粥样硬化组.中国儿童少年血脂防治专家共识[J].中国实用儿科杂志,2007,22(1):69-75.
[25]Jolley CD, Woollelt LA, Turley SD, et al. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein-1 concentration [J]. J Lipid Res, 1998, 39: 2143-2149.
[26]Ansell BJ, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by stimvastatin treatment [J]. Circulation, 2003, 108: 2751-2756.
[27]Richard L, Seip, et al. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not in adipose tissue[J]. AM Physiol, 1995, 268: E229-236.
[28]Kiens B, Lithell H. Lipoprotein Metabolism Influenced by Training Induced Changes in Human Skeletal Muscle [J]. J Clin Invest, 1989, 83(2):558-564.
[29]Thompson P D, Cullinane E M, Sady S P, et al. Modest Changes in High-density Lipoprotein Concentrations and Metabolism with Prolonged Exercise Training[J].Circulation, 1988, 78(1): 25-34.
[30]Witkowska AM. Soluble ICAM-1: A marker of vascular inflammation and lifestyle[J]. Cytokine, 2005, 31(2): 127-134.
[31]Sabin MA, Ford AL, Holly JM, et al. Characterisation of morbidityin a UK, hospital based, obesity clinic [J]. Arch Dis Child, 2006, 91(2): 126-130.
[32]Funahashi T, Matsuzawa Y. Metabolic syndrome:clinical concept and molecular basis [J]. Ann Med, 2007, 39(7): 482-494.
[33]Giannini C, DE Giorgis T, Scarinci A, et al. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children [J]. Atherosclerosis, 2008, 197(1): 448-456.
[34]杨晓冰,吴毅,李益明,等.运动对糖尿病大鼠骨骼肌细胞葡萄糖运载体4转位机制的影响[J].中华物理医学与康复杂志, 1999, 21(4): 2l4-215.
[1] Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity [J]. J Biol Chem, 1996, 271(18): 10697–10703.
[2]Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans [J]. Diabetes, 2002, 51(6): 1884-1888.
[3]Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase [J]. Nat Med, 2002, 8(11): 1288-1295.
[4]Stefan N, Stumvoll M, Vozarova B, et al. Plasma adiponectin and endogenous glucode production in humans [J]. Diabetes care, 2003, 26(12): 3315-3319.
[5]Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponection [J]. Circulation, 1999, 100(25): 2437-2476.
[6]Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin,a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptor [J]. Diabetes, 2003, 52(7): 1655-1663.
[7] Lim S, Koo BK, Cho SW, Kihara S, et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study[J]. Atherosclerosis, 2008, 196(1): 398-404.
[8]Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population[J]. Lancet, 2002, 360(9326):57–58.
[9] Daimon M, Oizumi T, Saitoh T, Kameda W, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study [J]. Diabetes Care, 2003, 26(7): 2015–2020.
[10]Hotta K, Funahashi T, Bodki N L, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parauel with reduced insulin sensitivity during the progression totype 2 diabetes in rhesus monkeys [J]. Diabetes, 2001, 50: 1126-1133.
[11]Matsubara M, Marucka S, Kataycses. Inverse relationship between plasama adiponectin and leptin concentrations in normal-weight and obese women[J]. European Journal of Endocrinology, 2002, 147(2): 173-180.
[12]Stefan N, Bunt JC, Sallbe AD, et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia [J]. J Clin Endocrinol Metab, 2002, 87(10): 4652-4656.
[13] Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin[J]. Circulation, 1999, 100(25):2473–2476.
[14] Balagopal P, George D, Yarandi H, et al. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents[J]. J Clin Endocrinol Metab, 2005, 90(11): 6192–6197.
[15] Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial [J]. JAMA, 2003, 289(14): 1799–1804.
[16]Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasama lipoproteins [J]. Diabetologia, 2003, 46(4): 459-469.
[17]Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel,adipose-specific protein,adiponectin, in type 2 diabetic patients [J]. Arteriosclerosis Thrombosis, and Vascular biology, 2000, 20(6): 1595-1599.
[18]Huang KC, Chen CL, Chuang LM, et al. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females [J]. J Clin Endocrinol Metab, 2003, 88(9): 4130-4134.
[19]Adamczak M, Wiecek A, Funahashi T, et al. Decreased plasma adiponetin conentration in patients with essential hypertension [J]. Am J Hypertens, 2003, 16(1): 72-75.
[20]Fasshauer M, Klein J, Neumann S, et al. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3-T3-L1 adipocytes[J]. FEBS Lett, 2001, 507(2): 142–146.
[21]Massiera F, Bluch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation [J]. FASEB J, 2001, 15(14): 2727–2729.
[22]李小平,杨成悌,张灵,等.高血压病患者血清脂联素水平的研究[J].中华心血管病杂志, 2004, 32 (7): 596-598.
[23]YANG WS, LEE WJ. Plasma adiponectin levels in overweight and obese Asians [J]. Obesity research, 2002, 10(11): 1104 -1101.
[24] Bluher M, Bullen Jr JW, Lee JH, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training [J]. J Clin Endocrinol Metab, 2006, 91(6): 2310-2316.
[25] Balagopal P, George D, Yarandi H, et al. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents [J] . J Clin Endocrinol Metab, 2005, 90(11): 6192-6197.
[26]Boudou P, Sobngwi E, Mauvais-Jarvis F, et al. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men [J]. Eur J Endocrinol, 2003, 149(5): 421-424.
[27]Soo Lim, Sung Hee Choi, In-Kyong Jeong, et al. Effects of Exercise on Adiponectin and Retinol-Binding Protein-4 Concentrations in Young and Middle-Aged Women [J]. J Clin Endocrinol Metab, 2008, 93(6): 2263-2268.
[28] Ryan AS, Nicklas BJ, Berman DM, et al. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women [J].Int J Obes Relat Metab Sisord JT,2003,27(9):1066-1071.
[29]井源,韩婷,吴静,等.瘦素在糖代谢中的作用及机制[J].国际病理科学与临床杂志, 2007, 27(5): 434-437.
[30]Sinha MK. Human Leptin: the hormone of adipose tissue[J]. Eur J Endocrinol, 1997, 136(5): 461-464.
[31]OSTLUND RE, YANG JIM, KLEIN S, et al. Relation between Plasma Leptin Concentration and Body Fat, Gender, Diet, Age, and Metabolic Covariate [J]. Clin Endo Metab, 1996, 81(11): 3909-3913.
[32]CARO JF, KOLACZYNSKI J W, NYCE M R, et al. Decreased Cerebrospinal Fluid/serum Leptin Ratioin Obesity: a Possible Mechanism for Leptin Resistance [J]. Lancet, 1996, 348(9021): 159-161.
[33]Considine RV, Sinha MK, Heiman ML, et al. Serum Immunoreactive-leptin Concentration in Normal weight and Obese Humans [J]. N Engl J Med, 1996, 334(5): 292-295.
[34]李静宜.瘦素抵抗的研究进展[J].国外医学:遗传学分册, 2003, 26(3): 166-169.
[35]Seufert J, Kiffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implication for the developmeng of adipogenic diabetes [J]. Clin Endocrinol Metab, 1999, 84(2): 670.
[36]Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in a adipose cells:regulation by insulin [J]. J Biol Chem, 1996, 271(5): 2365-2368.
[37]Landt M, Lawson G M, Helgeson J M, et al. Prolonged exercise devreases serum leptin concentrations [J]. Metabolism, 1997, 46(10): 1109-1112.
[38]Torjmail M C, Zafeirdis A, Paolone AM, et al. Serum Leptin During Recovery Following Maximal Incremental and Prolonged Exercise [J]. Sports Med, 1999, 20(7): 444-450.
[39]Essig DA, Alderson NL, Ferguson MA, et al. Delayed Effects of exercise on the plasma leptin concentration [J]. Metabolism, 2000, 49(3): 395-399.
[40]刘迅雷,李骁君,赵兰革,等.非饮食干预条件下耐力运动对单纯性肥胖儿童血压、血脂的影响[J].北京体育大学学报, 2002, 25(2): 198-199.
[41]Cerro AL, Luna PP, Astorga R, et al. Serum leptin levels in male marathon athletes before and after the marathon run[J]. Cline Endocrinol Metal, 1998, 83(7): 2376-2379.
[42]Jung SH, Park HS, Kim KS, et al. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight losss [J]. Journal of Nurtritional Biochemistry, 2008, 19(6): 371-375.
[43]柏建清.有氧运动对大鼠血清瘦素水平(leptin)的影响[J].天津体育学院学报,2008, 23(1): 74-76.
[44]Dirlewanger M, Di Vetta V, Giusti V, et al. Effect of moderate physical activity on plasma leptin concentration in human[J]. Appl Physiology and Occupational Physiology, 1999, 79(4): 331-335.
[45]何玉秀,白文忠,姚玉霞,等.运动对脂肪积累及肥胖基因表达的影响[J].体育科学, 1998, 18(3): 20-24.
[46]张缨.有氧运动训练对大鼠下丘脑食欲调节肽的影响[J].中国运动医学杂志, 2002, 21(1): 19-22.
[47]李翠珍,赵刚.不同游泳时间对高脂膳食大鼠血清瘦素及胰岛素水平的影响[J].中国科技信息, 2009, 24: 200-201.
[48] Pasman WJ, Westerterp-Plantenga MS, Saris WH.The effect of exercise training on leptin,levels in obese males[J]. Am J Physiol, 1998, 274(2): E 280-286.
[49]丛琳,陈吉棣.运动对糖尿病大鼠瘦素受体基因水平与功能的影响[J].体育科学, 2001,21(4): 54-57.
[50]Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes[J]. J Clin Invest, 2005, 115(5): 1111-1119.
[51]Hotamisligil GS. Inflammatory pathways and insulin action[J]. Int J Obesity, 2003, 27(Suppl 3): S53-S55.
[52]Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals[J].Int J Obesity, 2003, 27(Suppl 3): S25-S28.
[53]Nishimura S, Manabe I, Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome[J]. Discov Med, 2009, 8(41): 55-60.
[54]Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue initiation propagation and remodeling[J]. Future Lipidol, 2008, 3(5): 545-556.
[55]Pedersen BK, Bruunsgaard H. Possible beneficial role of exercise in modulating low-grade inflammation in the elderly [J]. Scand J Med Sci Sports, 2003, 13(1): 56- 62.
[56]沈海军,欧红芹,沈捷,等. IL-6在人单核细胞和脂肪细胞共培养体系中水平的相关变化[J].南京医科大学学报, 2010, 30(5): 649-652.
[57]Mohamed-A1i V, Goodriek S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumornecrsis factor-αin vivo[J]. J Clin Endocrinol Metab, 1997, 82(12): 4196-4200.
[58]Jens MB, Camilla V, Toubro S, et al. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α, effect of weight loss in obese men [J]. Eur J Endocrinol, 2003, 148(5): 535-542.
[59]Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome inmorbidly obese patients [J]. Arterioscler Thromb Vasc Biol, 2003, 23(6): 1042-1047.
[60]Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro[J]. J Clin Endocrinol Metab, 2002, 87(5): 2084-2089.
[61]Fernández-Real JM, Broch M, Vendrell J, et al. Interleukin-6 genepolymorphism and lipid abnormalities in healthy subjects[J]. J Clin Endo Meta, 2000, 85(3): 334-339.
[62]Papanicolaou DA , Petrides JS, Tsigos C, et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines[J]. Am J Physiol, 1996,271 (3Pt 1): E601-E605.
[63]Bhagat K, Vallance P. Inflammatory cytokines impair endothelium dependent dilatation in human veins in vivo [J]. Circulation, 1997, 96 (9): 3042-3047.
[64]Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis[J]. Br Heart J, 1993, 69 (1 suppl): S38-41.
[65]高从容,杨凌辉,王奇金,等.单纯性肥胖患者血清IL-6水平的变化及西布曲明减重治疗对其的影响[J].第二军医大学学报, 2004, 25(3): 317-319.
[66]Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid [J]. J Clin EndocrinolMetab, 1998, 83 (3): 847-850.
[67]Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial function in obese women after weight loss over one year [J]. Circulation, 2002, 105 (7): 804-809.
[68]Pedersen BK, Hoffmangoetz L. Exercise and the immune system: regulation, integration, and adaptation[J]. Physiol Rev, 2000, 80(3): 1055-1081.
[69]Febbraiom A, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles[J]. FASEB J, 2002, 16(11): 1335-1347.
[70]Ostrowski K, Rohde T, ASP S, et al. Chemokines are elevated in plasma after strenuous exercise in humans [J]. Eur J App1 Physio, 2001, 84(3): 244-245.
[71]Hulver MW, Houmard JA. Plasma leptin and exercise: recent findings [J]. Sports Med, 2003, 33(7): 473-482.
[72]王朝迅,裴海成,邱明才.运动减重对超重和肥胖者血清TNF-α、IL-6和CRP水平的影响[J].中国医师进修杂志, 2006, 29(10): 26-28.
[73]Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss[J].J Clin Endocrinol Metab, 2000, 85(9): 3338-3342.
[74]Pedersen BK, Bruunsgaard H. Possible beneficial role of exercise in modulating low-grade inflammati on in the elderly[J]. Scand J Med Sci Sports, 2003, 13 (1): 56-62.
[75] Hiroyuki H , Skazuo K. C-reactive protein is all independent predictor of the rate increase in early carotid atherosclerosis[J]. Circulation, 2001, 104 (1): 63-67.
[76]赵小松,朱依纯,姚泰.白细胞与原发性高血压[J].高血压杂志, 1998, 6 (1): 58-60.
[77] Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effects of C-reactive protein on human endothelin cells [J]. Circulation, 2000, 102 (18): 2165-2168.
[78]Moon YS, Ki m DH, Song DK. Serum tumor necrosis fact or alpha levels and components of the metabolic syndrome in obese adolescents[J]. Metabolism, 2004, 53 (7): 863-867.
[79]倪世宁,王大为,顾英霞,刘倩琦,朱子阳,沈金培,等.单纯性肥胖儿童胰岛素抵抗与肿瘤坏死因子-α的关系[J].实用儿科临床杂志, 2006, 21 (8) : 469-470.
[80]颜伟健,吴静,莫娟,等.肥胖儿童血浆脂联素与肿瘤坏死因子-α的变化及意义[J].中国当代儿科杂志.2009,11(1):47-50.
[81]Kern PA, Saghizadeh M, Ong JM et al. The expression of Tumor Necrosis Factor in Human Adipose Tissue: Regulation by Obesity Weight Loss, and Relationship to Lipoprotein Lipase [J]. J Clin Invest, 1995, 95(5): 2111-2119.
[82]Hauner H, Petruschke T, RussM. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia, 1995, 38(7): 764-771.
[83] Medeiros 1M, Reed S, Castelo A, et al. Circulation levels of sTNFR and discrepancy between cytotoxicity and immunorc activity of TNF alpha in patients with visceral leishmaniasis. Clin Micro Boil Infect, 2000, 6(1):34-37.
[84]Hotamisligil GS, Arner P, Atkinson RL, et al. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance [J]. Diabetes, 1997, 46(3): 451-455.
[85]Fernandez-Real JM,Broch M,Rican W,et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance [J]. Diabetes, 1998, 47(11): 1757-1762.
[86]Zahorska-Markiewic B, Janowska J, Olszanccka-Glinianowicz M, et al. Serum concentrations of TNF-αin obesity [J]. J Obes Relat Metab Disord, 2000, 24(11): 1392-1395.
[87] Shing-shin Yeh, Suh-yug Wu, Daniel M Levine, et al.The correlation of cytokine levels with body weight after megestrol acetate treatment in getiatric patients[J].The Journals of Gerontology, 2001, 56A: M48.
[88]Das UN. Is obesity an inflammatory condition [J]? Nutrition, 2001, 17(12): 953-966.
[89]Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition [J]. Diabetologia, 2005, 48(3): 519-528.
[90]O'Brien KD, Brehm BJ, Seeley RJ, et al. Diet induced weight loss is associated with decreases in plasma serum amyloid A and C reactive protein independent of dietary macronut rientcom position in obese subjects [J]. Clin Endocrinol Metab, 2005, 90(4): 2244-2249.
[91]Mohanty P, Aljada A, Ghanim H, et al. Evidence for a potent antiinflammatory effect of rosiglitazone [J]. Clin Endocrinol Metab, 2004, 89(6): 2728-2735.
[92]余舒杰.血清A-SAA与肥胖的关系.新医学, 2006, 37(3): 162-164.
[93]Danesh J, Muir J, Wong YK, et al. Risk factors for coronary heart disease and acute-phase proteins:a population-based study [J]. Eur Heart J, 1999, 20 (13): 954-959.
[94]Yang RZ, Lee MJ, Hu H, et al. Acute phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications[J].PLoS Med, 2006, 3(6): 884-894.
[95]Santos MG, Pegoraro M, Sandrini F, et al. Risk factors for the development of atherosclerosis in childhood and adolescence[J]. Arq Bras Cardiol, 2008, 90(4): 276-283.
[96]刘建凤,白伟,贾丽娟,等.超重肥胖儿童血清淀粉样蛋白A与颈总动脉内中膜厚度相关性研究[J].河北医药, 2010, 32(7): 827-828.
[97]Gómez-Ambrosi J, Azcona C, Patin o-García A, et al. Serum Amyloid A concentration is increased in obese children and adolescents [J]. J Pediatr, 2008, 153(1): 71-75.
[98]Godfrey SG, Catherine A. SAA, HDL biogenesis, and inflammation[J]. J Lipid Res, 2008, 49: 269-270.
[99]Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoproteins cellular affinity. A clue to serum amyloid A'sprincipal function [J]. Lab Invest, 1992, 66(6): 778-785.
[100]Ken O, Shinichi M, Youichiro W, et al. A serum amyloid A and LDL complex as a new prognostic marker instable coronary artery disease[J]. Atherosclerosis, 2004, 174(2): 349-356.
[101]Kazuhiko K, Noriko S, Yasuhisa K, et al. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL is associated with obesity and the metabolic syndrome [J]. Atherosclerosis, 2009, 204(2): 526-531.
[102]陈瞒,余舒杰,赵长林等.中老年人血清淀粉样蛋白水平与体育运动及吸烟的关系.中国临床康复[J]. 2005, 47(9): 14-16.
[103] Rothenbacher D, Hoffmeister A, Brenner H, et al. Physical activity coronary heart disease, and inflammatory response[J]. Arch Itern Med 2003, 163(10): 1200-1205
[104]温先勇,杭永伦,邓辉胜等.氧化应激和炎症反应在冠心病中的作用及其相互关系[J].中国临床康复, 2005, 9(11): 38-39.
[105] Williams PT. High-density lipoprotein cholesterol and other rise factors for coronary heart disease in female runners[J]. N Engl J Med, 1996, 334(20): 1298-1303.
[106]王兵,李毅军.运动对冠心病患者的康复作用[J].中国临床康复, 2003, 7(12): 1843.
[107]Verdaet D, Dendale P, Bacquer DD, et al. Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease[J]. Atherosclerosis, 2004, 176(2): 303-310.
[108]Pitsavos C, Chrysohoou C, Panagiotakos DB, et al. Association of leisure time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloidA, and fibrinogen) in healthy subjects (from the ATTI CA Study)[J]. Am J Cardiol, 2003, 91(1): 368-370.
[109]Julia K, Christian K, Roberts, Tung H, et al. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease[J]. Metabolism, 2004, 53(3): 377-381.
[1]Cooke JP, Tsao PS. Is NO an endogenous antiatherogenic molecule? [J]Arterioscler Thromb, 1994, 14(5): 653-655.
[2]Creager MA, Cooke J P, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans[J]. J Clin Invest, 1990, 86 (1): 228-234.
[3]汪翼,牛峰海,寻文龙,等.单纯性肥胖儿童血管内皮分泌功能和内皮依赖性舒张功能障碍的研究[J].中华儿科杂志, 2000, 38(7): 86-88.
[4]殷松楼,张慧宝.运动对大鼠主动脉损伤后内皮素和一氧化氮合酶的影响[J].中国心血管康复医学, 1997, 6(1-2): 11-16.
[5]唐小梅,孙焱,黄叔怀.不同运动训练对大鼠心血管内分泌功能的影响[J].现代康复, 2001, 5(4): 40-41.
[6]常芸,林福美.不同类型运动心脏的内分泌改变特征[J].中国运动医学杂志, 1996, 15(3): 162.
[7]Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J.The effect of weight loss on serum concentrations of nitric oxide,TNF-αand soluble TNF-αreceptors[J]. Endokrynologia Polska, 2006, 57(5): 487-493.
[8]Kingwell B A, Sherrard B, Jennings G L, et al. Four weeks of cycle training increases basal production of nitric oxide from the forearm [J]. Am J Physiol, 1997, 272(3 Pt 2): H1070-1077.
[9]Asako M, Seiji M, Mutsuko Y, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men[J]. Angiology, 2009, 60(3): 351-357.
[10] Green D, Maiorana A, O’Driscoll G, et al. Effect of Exercise Training in Endothelium-derived Nitric Oxide Function in Humans[J]. J Physiol, 2004, 561 (Pt 1):1-25.
[11]Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability[J]. Circulation, 2002, 106(20): 2530-2532.
[12]Esposito K, Marfalla R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome:a randomized trial [J]. JAMA, 2004, 292(12): 1440-1446.
[13]陈瑶,李倩,汪翼,等.肥胖儿童血浆血管假性血友病因子与动脉粥样硬化指数的相关性分析[J].中国实用儿科杂志, 2006, 21(11): 865-866.
[14]Garanty-Bogacka B, Syrenicz M, Syrenicz A. Serum markers of inflammation and endothelial activati on in children with obesity-related hypertension [J]. Neurol Endocrinol Lett, 2005, 26 (3):242-246.
[15]王振义主编.血栓与止血(基础与临床)[M].上海:科学技术出版社, 1988, 30-264.
[16]李宁川,黄叔怀.运动与血管假血友病因子[J].中国临床康复, 2004, 8(18): 3618-3619.
[17] Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9): 1135-1143.
[18]Witokwska AM. Soluble ICAM-1: A Maker of Vascular inflammation and lifestyle [J]. Cytokine, 2005, 31(2): 127-134.
[19]Gavin J, Paul M. Novel clinical marker of vascular wall inflammation[J]. Circulation research, 2001, 89(9): 763.
[20]Adamopoulos S, Parisis J, Kroupis C, et al. Physical training reduces peripheral marker of inflammation in patients with chronic heart failure [J]. Eur heart J, 2001, 22(9): 791-797.
[21]Glowinska B, Urban M, Peczynska J, et al. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes [J]. Metabolism, 2005, 54 (8): 1020-1026.
[22]Ramírez MM, García MI, Bahri E, et al. Effect of a high glucose load on serum adhesion markers in obese women[J]. Med Clin (Barc), 2009, 132 (11), 407-413.
[23]Marchesi S, Vaudo G, Lupattelli G, et al. Fat distribution and endothelial function in normal-overweight menopausal women[J]. Journal of Clinical Pharmacy and Therapeutics, 2007, 32(5): 477-482.
[24]郭英,王玉,王纯等.亚极量踏车运动对血清sICAM-1表达水平的影响[J].四川体育科学, 2006, 2:22-24.
[25]Nieman DC. Exercise and resistance to infection[J]. Can J Physiol Pharmacol, 1995, 76(5): 573-580.
[26]Nielsen HG., Lyberg T. Long-Distance Running Modulates the Expression of Leucocyte and Endothelial Adhesion Molecules [J]. Scand J Immunol, 2004, 60(4): 356-362.
[27]王金良,谭峰,丁德权等.早期综合康复治疗对急性脑梗死患者运动功能、sICAM-1和IL-6的影响[J].中国医药导报, 2009, 22(2): 27-29.
[28]Mogharnasi M, Gaeini AA, Javadi E, et al. The effect of endurance training on inflammatory biomarkers and lipid profiles in wistar rats[J]. World Journal of Sport Sciences, 2009, 2(2): 82-88.
[29]Yannakoulia M, Chrousos GP, Sidossis LS. Aerobic exercise training improves insulin sentivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls [J]. Metabolism, 2005, 54(11): 1472-1479.
[30]Hammett CJ, Prapavessis H, Baldi JC, et al. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk [J]. American Heart J, 2006, 151(2): 367.e7-367.e16.
[31]Wegge JK, Roberts CK, Ngo TH, et al. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease [J]. Metabolism, 2004, 53(3): 377-381.
[32]尚金华,黄文英.运动抗炎症作用机制研究[J].浙江体育科学, 2008, 30 (6): 97-99.
[33]WEISBERG S P, MCCANN D, DESAI M, et al. Obesity is as sociated with macrophage accumulation in adipose tissue[J]. J Clin Invest, 2003, 112(12): 1796-180.
[34]Giltay EJ, Elbers JM, Gooren LJ, et al. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women modulation by cross-sex hormone administration [J]. Thromb Vasc Biol, 1998, 18(11): 1716-1722.
[35]Dietzmann K, Von BP, Krause D, et al. Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study[J]. Pathol Res Pract, 2000, 196 (1): 15-21.
[36]Cigolini M, Targher G, Bergamo Andreis IA, et al. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men[J].Arterioscler Thromb Vacs Biol, 1996, 16(3): 368-370.
[37]Meilahm EN, Cauley JA, Tracy RP, et al. Association of sex hormones and adiposiry with plasma concentrations of fibrinogen and PAI-1 in postmenopausal women [J]. AMJ Epidemiol, 1996, 143(2): 159-162.
[38]Sawdey MS, Lockutoff DJ. Regulation of murine type I plasminogen activator by inhibitor gene expression in vivo, tissue specificity and induction by lipopolysaccharide tumor necrosis factor alpha and transformin growth factor beta [J]. J Clin Invest, 1991, 88(4): 1346-1348. [ 39 ]Salomaa V, Stinson V, Kark JD. Association of fibrionlytic parameters with early atherosclerosis the ARIC study atherosclerosis risk incommunities study [J]. Circulation, 1995, 91(2): 284-290.
[40]崔克勤,苏胜偶,尹博英,等. 2型糖尿病合并冠心病与血浆纤溶酶原激活物抑制剂-1水平的相关性研[J].临床荟萃, 2006, 21(16): 1150-1152.
[41]陈弹,程绪杰,李红霞,等.肿瘤坏死因子α和血管紧张素Ⅱ对内皮细胞释放PAI-1的影响[J].中国血液流变学杂, 2003, 13(3): 219-224.
[42]Legnani C, Maccaferri M, Tonini P, et al. Reduced fibrinolytic response in obese children: association with high baseline activity of the fast acting plasmino genactivator inhibitor-1(PAI-1) [J]. Fibrinolysis, 1988, 2: 211-213.
[43]El-Sayed MS, Sale C, Jones PG, et al. Blood hemostasis in exercise and training[J]. Med Sci Sports Exerc, 2000, 32(5): 918-925.
[2]Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases [J]. Diabetes Metab Res Rev, 2006, 22(6): 423-436.
[3]Asako M, Seiji M, Mutsuko Y, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men[J]. Angiology, 2009, 60(3): 351-357.
[4]Makimattila S, Yki-Jarvinen H. Endothelial dysfunction in human diabetes[J].Curr Diab Rep 2002, 2(1): 26-36.
[5]Chobanian AV, Bakris GL, Black HR, et al.The seventh report of the joint national committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: the JNC 7 Report[J]. JAMA, 2003, 289(19): 2560-2572.
[6] Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance[J]. Circulation, 2000, 101(15): 1780-1784.
[7]王钢.冠心病血管内皮功能障碍的评价[J].锦州医学院学报, 2005, 26(2): 56. [ 8 ]赵玉英,智光.评价血管内皮功能的方法[J].中华老年心脑血管病杂志,2004, 16(3):208-210.
[9] Vincent MA, Barrett EJ, Lindner JR, et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin[J]. Am J Physiol Endocrinol Metab, 2003, 285(1): E123-E129.
[10]Kuvin JT, Karas RH. Clinical utility of endothelial function testing: ready for prime time? [J]. Circulation, 2003, 107(25): 3243-3247.
[11]Meyer AA, Kundt G, Lenschow U, et al. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program [J]. J Am Coll Cardiol, 2006, 48(9): 1865-1870.
[12]Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force [J]. J Am Coll Cardiol, 2000, 39(2): 257-265.
[13] Eskurza I, Seals DR, DeSouza DA, et al. Pharmacological vs flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans[J]. Am J Cardiol, 2001, 88(9): 1067-1069.
[14]Spranger J, Kroke A, Mohlig M, et al. Infammatory cytokines and the risk to develop type 2 diabetes, results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study[J]. Diabetes, 2003, 52(3): 812-817.
[15]Pradham AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin-6 and the risk of developing type 2 diabetes mellitus[J]. JAMA , 2001, 286(3): 327-334.
[16]Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from humanendothelial cells and modulates its circulating levels in vivo[J]. J Clin Endocrinol Metab, 1995, 80(3): 829-835.
[17]Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation[J]. Nat Rev Immunol, 2007, 7(10): 803–815.
[18]Schwartz CJ, Valente AJ, Sprague EA. A modern view of atheroselerosis[J]. Am J Cardiol, 1993, 71(6): 9B-14B.
[19]Ludmer P, Selwyn A, Shook T, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries[J]. N Engl J Med, 1986, 315(17): 1046-1051.
[20]Van Guilder GP, Stauffer BL, Greiner JJ, et al. Impaired endothelium-dependent vasodilation in overweight and obese adults humans is not limited to muscarinic receptor agonist[J]. Am J Physiol Heart Circ Physiol, 2008, 294(4): H1685-H1692.
[21]Brook RD, Bard RL, Rubenfire M, et al. Usefulness of visceral obesity(waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults[J]. Am J Cardiol, 2001, 88(11): 1264-1269. [ 22 ]Moncada S, Palmer RM, Higgs EA. Nitricoxide: physiology, pathophysiology, and pharmacology [J]. Pharmacol Rev, 1991, 43(2): 102-142.
[23]Oflaz H, Ozbey N, Mantar F, et al. Determination of endothelial function and early atherosclerotic changes in healthy obese woman [J]. Diabetes Nutr Metab, 2003, 16(3): 176-181.
[24]陈瑶,汪翼,李燕等.不同干预方法对实验性肥胖大鼠早期血管内皮功能障碍作用的比较[J].中华儿科杂志, 2006, 44(8): 607-610.
[25]朱旅云.超重和肥胖对血管内皮功能的影响[J].中华心血管病杂志, 2001, 29(12): 750-752.
[26]彭向峰.单纯性肥胖少儿血内皮素、血脂的改变及耐力运动对其影响的研究[J].中国运动医学杂志, 2000, 19(2): 167-173.
[27]Nofer JR, Toll M, Ciet M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor SIP3 [J]. J Clin Invest, 2004, 113(4): 569-581.
[28]Esposito K, Marfalla R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome:a randomized trial [J]. JAMA, 2004, 292(12): 1440-1446.
[29]Valle Jiménez M, Estepa RM, Camacho RM, et al. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children [J]. Eur J Endocrinol, 2007, 156 (4): 497-502.
[30]Hilberg T, Nowacki PE, Muller-berghaus G, et al. Changes in blood coagulation and fibtinolyais associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives [J]. J Sci Med Sport, 2000, 3(4): 83-90.
[31]Rohde LE, Lee RT, Rivero J, et al. Circulating cell adhesion molecules correlate with ultrasound-based assessment of carotid atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 1998, 18(11): 1765-1770.
[32]Shai I, Pischon T, Hu FB, Ascherio A, et al. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease [J]. Obesity, 2006, 14(11): 2099-2106.
[33]Vanderwall AC, Das PK, Tigges AJ, et al. Adhension molecules on the endothelium and mononuclear cells in human atherosclerotic lesions [J]. Pathol, 1992, 141(6): 1427-1433.
[34]Valle Jiménez M, Estepa RM, Camacho RM, et al. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children[J]. Eur J Endocrinol, 2007, 156 (4): 497-502.
[35]Buchwalter G, Gross C, Wasylyk B, et al. The ternary Complex factor Net regulates cell migration through migration through inhibition of PAI-1 expression [J]. Mol Cell Biol, 2005, 25(24): 10853-10862.
[36]Bastelica D, Morange P, Bert het B, et al. Stromal cells are the main plasminogen activat or inhibit or producing cells in human fat:evidence of differences between visceral and subcutaneous deposits [J]. Arterioscler Thromb Vasc Biol, 2002, 22 (1): 173-178.
[37]Solano M P, Perry A C, Wang X, et al. Insulin resistance but not visceral adipose tissue is associated with plasminogen activat or inhibit or type 1 levels in overweight and obese p remenopausal African-American women [J]. Int J Obes Relat Metab Disord, 2003, 27(1): 82-87.
[38]Glowinska B, Urban M, Koput A, et al. Selected new at herosclerosis risk f act ors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes [J]. Przegl Lek, 2000, 60 (1): 12-17.
[39] Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system [J]. Obes Rev, 2002, 3 (2): 85-101.
[40]王宁,喻书彻,王瑛等.儿童单纯性肥胖症凝血、纤溶指标的测定及其意义[J].中国儿童保健杂志, 2000, 8(5): 302-304. [ 41 ]Salomaa V, Stinson V, Kark JD. Association of fibrionlytic parameters with early atherosclerosis the ARIC study atherosclerosis risk in communities study [J]. Circulation, 1995, 91(2): 284-290.
[42]Cigolini M, Targher G, Bergamo Andreis IA, et al. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men [J]. Arterioscler Thromb Vacs Biol, 1996, 16(3): 368-370.
[43]Mlahm EN, Cauley JA, Tracy RP, et al. Association of sex hormones and adiposiry with plasma concentrations of fibrinogen and PAI-1 in postmenopausal women [J]. AM J Epidemiol, 1996, 143(2): 159-162.
[44]Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases:the role of oxidant stress [J]. Circ Res, 2000, 87: 840-844.
[45]Erdei N, Toth A, Pasztor ET, et al. High-fat diet-induced reduction in nitricoxide-dependent arteriolar dilation in rats:role of xanthine oxidase-derived superoxide anion [J]. Am J Physiol Heart Circ Physiol, 2006, 291(5): H2107–H2115.
[46]ZHU LY, LIU KS. Study of insulin resistance and insulin secretion function in overweight and obese subjects with endothelial dysfunction[J]. China Journal of Modern Medicine, 2004, 14(14): 27-30.
[47]Nigro J, Osman N, Dart AM, et al. Insulin resistance and atherosclerosis [J]. Endocr Rev, 2006, 27(3): 242-259.
[48]Gomez Rosso L, Benitez MB, Fornari MC, et al. Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome [J]. At herosclerosis, 2008, 1999(2): 415-423.
[49]Amar J, Perez L, Burcclin R, et al. Arteries, inflammation and insulin resistance [J]. J Hypertens Suppl, 2006, 24(5): S18-20.
[50]Fay WP. Plasminogen activator inhibitor-1, fibrin, and the vascular response to injury [J].Trends Cardiovasc Med, 2004, 14(5): 196-202.
[51]Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes[J]. Science, 2005, 307 (5708): 384-387.
[52]Kershaw EE, Flier JS. Adipose tissue as an endocrine organ[J]. J Clin endocrinol Metab, 2004, 89(6): 2548-2556.
[53]Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of Plasma Protein encoded by the obese gene [J]. Science, 1995, 269(5223): 543-546.
[54] Bouloumie A, Marumo T, Lafontan M, et al. Leptin induces oxidative stress in human endothelial cells [J]. FASEB J, 1999, 13(10): 1231-1238.
[55]Kang SM, Kwon HM, Hong BK, et al. Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization [J].Yonsei Med J, 2000, 41(1): 68-75.
[56]Vecchione C, Aretini A, Maffei A, et al. Cooperation between insulin and leptinin the modulation of vascular tone [J]. Hypertension, 2003, 42(2): 166-170.
[57]Quehenberger P, Exner M, Sunder R, et al. Leptin induces endothelin-1 in endothelial cells in vitro [J]. Cire Res, 2002, 90 (6): 711-718.
[58]De Mitrio V, De Pergola G, Vettor R, et al. Plasma plasminogen activator inhibitorl is associated with plasma with lepin irrespetive of body mass index, bodv fat mauss and plasma insulian and metabolic parameters in premenopausal women [J]. Metabolism, 1999, 48(8): 960-964.
[59]Rahmouni K, Morgan DA, Morgan GM, et al. Role of selective leptin resistance in diet-induced obesity hypertension [J]. Diabetes, 2005, 54(7): 2012-2018.
[60]Chen K, Li F, Li J, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin [J]. Nat Med, 2006, 12(4): 425–432.
[61] Park HY, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro [J]. Exp Mol Med, 2001, 33(2): 95-102.
[62]Kang SM, Kwon HM,Hong BK, et al. Expression of leptin receptor in human atherosclerotic lesion:potential role in intimal neovascularization [J]. Yonsei Med J, 2000, 41(1): 68-75.
[63]Wolf G, Hamann A, Ham DC, et al. Leptin stimulates proliferation and TGF-βexpression in renal glomerular endothelial cells: potential role in gromerulosclerosis [J]. Kidney Int, 1999, 56(3): 860-872.
[64]Ribatti D, Nico B, Belloni AS, et al. Aigiogenic activity in the chick embryo chofioallantoic membrane is in part mediated by endogenous fibroblast growth factor [J]. Int J Mol Med, 2001, 8(3): 265.
[65]Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells [J]. FASEB J, 1999, 13(10): 1231-1238.
[66]Yamagishi S, EdelStein D, Du X, et al. Leptin induces mitochondnial superoxide production and monoeyte chemoattractant protein-1 expression in aortic endothelial cells by increasing factory acid oxidation via protein kinase A [J]. J Biol Chem, 200l, 26(27): 25096-25100.
[67]Stefan N, Bunt JC, Salbe AP, et al. Plasma adiponectin concentrations in obese children: relationship with obesity and insulinemia [J]. J Clin Endocrinol Metab, 2002, 87(10): 4652-4656.
[68]Hara T, Fujiwara H, Shoji T, et al. Decreased plasma adiponectin levels in young obese males [J]. J Atheroscler Thromb, 2003, 10 (4): 234-238.
[69]Asayama K, Hayashibe H, Dobashi K, et al. Decrease in serum adiponectin level due to obesity and visceral f at accumulation in children [J]. Obes Res, 2003, 11(9): 1072 -1079.
[70]Ouchi N, Kihara S, Funahashi T, et al. Obesity adiponectin and vascular inflammatory disease [J]. Cur r Opin Lipidol, 2003, 14 (6): 561-566.
[71]Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities [J]. J Mol Med, 2002, 80(11): 696 -702.
[72]Chandran M, Phillips SA, Ciaraldi T, et al. Adiponectin: more than just another fat cell hormone [J]. Diabetes Care, 2003, 26(8): 2442-2450.
[73]Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome[J]. J Intern Med, 2005, 257(2): 167-175.
[74]Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia [J]. J Clin Endocrinol Metab, 2001, 86(5): 1930-1935.
[75]Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia[J]. Clin Endocrinol Metab, 2002, 87(6): 2764-2769. [ 76 ]Kojima S, Funahashi T, Sakamoto T, Miyamoto S, et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction [J]. Heart, 2003, 89(6): 667-672.
[77]Kumada M, Kihara S, Sumitsuji S, Kawamoto T, et al. Association of hypoadiponectinemia with coronary artery disease in men [J]. Arterioscler Thromb Vasc Biol, 2003, 23(1): 85-89.
[78]Kazumi T, Kawaguchi A, Sakai K, et al. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure [J]. Diabetes Care, 2002, 25(6): 971-976.
[79]Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obestiy,insulin resistance,and hypercytokinemia [J]. J Clin Endocrinol Metab, 2000, 85(3): 1151-1158. [ 80 ]Margolis KL, Manson JE, Greenland P, et al. Leuokocyte count as a predictor of cardiovascular events and mortality in postmenopausal women:the Women's Health Initiative Observational Study [J]. Arch Intern Med, 2005, 165(5): 500-508.
[81]Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year [J]. Circulation, 2002, 105(7): 804-809.
[82]Perticone F, CeravoloR, Candigliota M, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: Protective effect of vitamin C[J]. Diabetes, 2001, 50(1): 159-165.
[83]Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase [J]. J Clin Invest, 1995, 95(5): 2111-2119.
[84]Li G, Barrett EJ, Barrett MO, et al. Tumor Necrosis Factor-αinduces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway[J]. Endocrinology, 2007, 148(7): 3356-3363.
[85] Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J]. J Clin Endocrinol Metab, 2000, 85(9): 3338-3342.
[86]Vozarova B, Weyer C, Hanson K, et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion [J]. Obes Res, 2001, 9(7): 414-417.
[87]Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance[J]. Diabetologia, 2003, 46(12): 1594-1603.
[88]Albert CM, Ma J, Rifai N, et al. Prospective study of C-Reactive protein,homocysteine,and plasma lipid levels as predictors of sudden cardiac death[J].Circulation, 2002,105(22): 2595-2599.
[89]Fichtlscherer S. Elevated CRP levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J]. Circulation, 2000, 102(9): 1000-1006.
[90]Kang SM, Chung N, Kim JY, et al. Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary disease[J]. Echocardiography, 2002, 19(8): 661-667.
[91]Gillum R F. Association of serum Creactive protein and indices of body f at distribution and overweight in Mexican American children[J]. J Natl Med Assoc, 2003, 95(7): 545-552.
[92]Jarvisalo MJ, Harmoinen A, Hakanen M, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children[J]. Arterioscler Thromb Vasc Biol, 2002, 22(8): 1323-1328.
[93]Tomai F. C reactive p rotein and microvascular f unction [J]. Heart, 2004, 90 (7): 727-728.
[94]Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediat or in at herothrombosis [J]. Hypertension, 2004, 44 (1): 6-11.
[95]Hatanaka E, Monteagudo PT, Marrocos MS, et al. Interaction between serum amyloid A and leukocytes-a possible role in the progression of vascular complications in diabetes [J]. Immunol Lett, 2007, 108(2): 160-166.
[96]JOUSILAHTI P, SALOMAA V, RASIV, et al. The association of C-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease-baseline findings of the PAIS project [J]. Atherosclerosis, 2001, 156 (2): 451-456.
[97]Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, et al. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass[J].Obes Surg, 2006, 16(3), 262-269.
[98]Gómez-Ambrosi J, Azcona C, Pati?o-García A, et al. Serum Amyloid A concentration is increased in obese children and adolescents [J]. J Pediatr, 2008, 153 (1): 71-75.
[99]余舒杰,刘金来.血清淀粉样蛋白A与冠心病的相关性研究[J].岭南心血管病杂志, 2005,11(4):252-255.
[100]Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes[J]. Diabetes Care, 2008, 31(supplement 2): S297–S302.
[101]Yao X Q, Liu F K, Qi X P, et al. Expression of survivin in human gastric adenocarcinomas: correlation and apoptosis [J]. Chin J Surg, 2004, 42(3): 145-148.
[102]Bergholm R, Tiikkainen M, Vehkavaara S, et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes [J]. Diabetes Care, 2003, 26(6): 1667-1672.
[103]Fonseca VA. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus[J]. Am J Med, 2007, 120 (9 Supp l 2): 18-25.
[104] Bojunga J, Nowak D, Mitrou PS, et al. Antioxidative treatment prevents activation of death receptor and mitochondrion-dependent apoptosis in the hearts of diabetic rats [J]. Diabetologia, 2004, 47(12): 2072-2080.
[105]Sena CM, Nunes E, Louro T, et al. Endothelial dysfunction in type 2 diabetes: effect of antioxidants [J]. Rev Port Cardiol, 2007, 26 (6): 609-619.
[106]曹建华.辛伐他丁对冠心病患者CRP、vWF、NO及ET-1的影响[J].中国老年学杂志, 2010, 30(8): 1138-1139.
[107]Waldinai PF, Marcelo CB, Simone NS, et al. One-Month Therapy With Simvastatin Restores Endothelial Function in Hypercholesterolemic Children and Adolescents [J]. Pediatr Cardiol, 2007, 28(1): 8-13.
[108]Pe?a AS, Wiltshire E, Gent R, et al. Folic acid does not improve endothelial function in obese children and adolescents [J]. Diabetes Care, 2007, 30 (8): 2122-2127.
[109]Sasaki S, Higashi Y, Nakagawa K, et al. A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension [J]. Am J Hyperten, 2002, 15(4): 302-309.
[110]Nicoletti G, Gugliano G, Pontillo A, et al. Effect of a multidisciplinary program of weight reduction on endothelial function in obese women [J]. J Endocrinol Invest, 2003, 26 (3): RC5.
[111]朱旅云,胡丽叶,王广宇等.单纯性肥胖者减重效果与血管内皮功能和胰岛素抵抗的关系[J].现代预防医学, 2008, 35(19): 3843-3845.
[112]Tanriverdi H, Evrengul H, Tanriverdi S, et al. Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism[J]. Circ J, 2005, 69(9): 1105-1110.
[113]Maeda S, Miyauchi T, Kakiyama T, et al. Effects of exercise training of 8 weeks and det raining on plasma levels of endothelium-derived factors, endothelin-1 and nitricoxide, in healthy young humans [J]. Life Sci, 2001, 69(9): 1005-1016.
[114]Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome[J]. Arteroiscler Thromb Vasc Biol, 2000, 20(2): 551-555.
[115]Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease [J]. N Engl J Med, 2000, 342(7): 454-460.
[116]都健.运动对胰岛素抵抗大鼠内皮依赖性血管舒张功能干预效应的研究[J].中国糖尿病杂志, 2003, 11(4): 268-271.
[117]Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure [J]. Circulation, 1996, 93(2): 210-214.
[118]Schmidt A, Pleiner J, Bayerle-Eder M, et al. Regular physical exercise improves endothelial function in heart transplant recipients [J]. Clin Transplant, 2002, 16(2): 137-143.
[119]Goto C, Higashi Y, Kimura M, et al. Effect of Different Intensities of Exercise on Endothelium-Dependent Vasodilation in Humans [J]. Circulation, 2003, 108(5): 530-535.
[120] Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children [J]. Circulation, 2004, 109(16): 1981-1986.
[121]Moien-Afshari F, Ghosh S, Khazaei M, et al. Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice [J]. Diabetologia, 2008, 51(7): 1327-1337.
[122]Gielen S, Erbs S, Linke A, et al. Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion[J]. Am Heart J, 2003, 145(1): E3.
[1]Charles MA. Early nutrition and weight evolution in children[J]. Ann Endocrinol, 2005, 66 (2): 11-18.
[2]Lawlor DA, Smith GD. Early life determinants of adult blood pressure [J]. Curr Opin Mphrol Typertens, 2005, 14 (3): 259-264.
[3]Grievink L, Alberts JF, O'Niel J, et al. Waist circumference as a measurement of obesity in the Nehgerlands Antilles;associations with hypertension and diabetes mellitus [J]. Eur J Clin Nutr, 2004, 58(8): 1159-1165.
[4]Hagan RD, Upton SJ, Wong L, Whittam J. The effects of aerobic conditioning and/or calorie restriction in overweight men and women[J]. Med Sci Sports Exerc, 1986, 18(1): 87-94.
[5]National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report[J].Obes Res, 1998, (6 suppl 2): 51S–209S.
[6]Ross R, Dagnone D, ones PJH, et al. Eduction in obesity and related comorbid conditions after diet induced weight loss or exercise-induced weight loss in men [J]. Ann Intern Med, 2000, 133(2): 92-103.
[7]中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值适宜体重指数和腰围切点的研究[J].中华流行病学杂志, 2002, 23(1): 5-10.
[8]林华,王洪.有氧健身操对中老年女性BMI和WHR的影响[J].体育科学, 2000, 20(3): 63-65.
[9]郑澜,房美玉,周建社等.有氧运动与针刺穴位对大鼠腹部脂肪及各项指标影响的研究[J].中国体育科技, 2006, 42(2): 122-124.
[10]季钢,刘艺,陈晓丽等.对肥胖青少年血压计脑血流动力学变化的研究.首都体育学院学报, 2005, 17(2): 115-116.
[11]Peco-Anti? A.Hypertension in obese children and adolescents[J]. Srp Arh Celok Lek, 2009, 137 (1-2): 91-97.
[12]Torrance B, McGuire KA, Lewanczuk R, et al. Overweight, physical activity and high blood pressure in children: a review of the literature[J]. Vasc Health Risk Manag, 2007, 3 (1): 139-149.
[13]Lazarus R, Gore CJ, Booth M, et al. Effects of body composition and fat distribution on ventilatory function in adults [J]. Am J Clin Nutr, 1998, 68(1): 35-41.
[14]Zerah F, Harf A, Perlemuter L, et al. Effects of obesity on respiratory resistance [J]. Chest, 1993, 103(5): 1470-1476.
[15]Conway B, Rene A. Obesity as a disease no light weight matter[J]. Obes Rev, 2004, 5(3): 145-151.
[16]Biring MS, Lewis MI, Liu JT, et al. Pulmonary physiologic changes of morbid obesity [J]. Am J Med Sci, 1999, 318(5): 293-297.
[17]Pankow W, Podszus T, Gutheil T, et al. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity [J]. J Appl Physiol, 1998, 85(4): 1236-1243.
[18]Rubinstein I, Zamel N, DuBarry L, et al. Airflow limitation in morbidly obese, nonsmoking men[J]. Ann Intern Med, 1990, 112(11): 828-832.
[19]Nemet D, Wang P, Funahashi T, et al. Adipocytokines body composition and fitness in children [J]. Pediatr Res, 2003, 53(1): 148-152.
[20]Moon YS, Kim DH, Song DK. Serum tumor necrosis factor alpha levels and components of the metabolic syndrome in obese adolescents [J]. Metabolism, 2004, 53(7): 863-867.
[21]Jubber AS. Respiratory complications of obesity[J]. Int J Chin Pract, 2004, 58(6): 573-580.
[22]WEISS R, CAPRIO S.The metabolic consequences of childhood obesity[J]. Best Pract Res Clin Endocrinol Metab, 2005, 19(3): 405-419.
[23]许逢明,黄宇戈,温杨祥,等.单纯性肥胖儿童血脂水平与血管内皮功能的相关性研究[J].中国妇幼保健, 2005, 20(11): 1361-1363.
[24]中国医师协会儿童健康委员会,中华心血管病协会动脉粥样硬化组.中国儿童少年血脂防治专家共识[J].中国实用儿科杂志,2007,22(1):69-75.
[25]Jolley CD, Woollelt LA, Turley SD, et al. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein-1 concentration [J]. J Lipid Res, 1998, 39: 2143-2149.
[26]Ansell BJ, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by stimvastatin treatment [J]. Circulation, 2003, 108: 2751-2756.
[27]Richard L, Seip, et al. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not in adipose tissue[J]. AM Physiol, 1995, 268: E229-236.
[28]Kiens B, Lithell H. Lipoprotein Metabolism Influenced by Training Induced Changes in Human Skeletal Muscle [J]. J Clin Invest, 1989, 83(2):558-564.
[29]Thompson P D, Cullinane E M, Sady S P, et al. Modest Changes in High-density Lipoprotein Concentrations and Metabolism with Prolonged Exercise Training[J].Circulation, 1988, 78(1): 25-34.
[30]Witkowska AM. Soluble ICAM-1: A marker of vascular inflammation and lifestyle[J]. Cytokine, 2005, 31(2): 127-134.
[31]Sabin MA, Ford AL, Holly JM, et al. Characterisation of morbidityin a UK, hospital based, obesity clinic [J]. Arch Dis Child, 2006, 91(2): 126-130.
[32]Funahashi T, Matsuzawa Y. Metabolic syndrome:clinical concept and molecular basis [J]. Ann Med, 2007, 39(7): 482-494.
[33]Giannini C, DE Giorgis T, Scarinci A, et al. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children [J]. Atherosclerosis, 2008, 197(1): 448-456.
[34]杨晓冰,吴毅,李益明,等.运动对糖尿病大鼠骨骼肌细胞葡萄糖运载体4转位机制的影响[J].中华物理医学与康复杂志, 1999, 21(4): 2l4-215.
[1] Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity [J]. J Biol Chem, 1996, 271(18): 10697–10703.
[2]Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans [J]. Diabetes, 2002, 51(6): 1884-1888.
[3]Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase [J]. Nat Med, 2002, 8(11): 1288-1295.
[4]Stefan N, Stumvoll M, Vozarova B, et al. Plasma adiponectin and endogenous glucode production in humans [J]. Diabetes care, 2003, 26(12): 3315-3319.
[5]Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponection [J]. Circulation, 1999, 100(25): 2437-2476.
[6]Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin,a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptor [J]. Diabetes, 2003, 52(7): 1655-1663.
[7] Lim S, Koo BK, Cho SW, Kihara S, et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study[J]. Atherosclerosis, 2008, 196(1): 398-404.
[8]Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population[J]. Lancet, 2002, 360(9326):57–58.
[9] Daimon M, Oizumi T, Saitoh T, Kameda W, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study [J]. Diabetes Care, 2003, 26(7): 2015–2020.
[10]Hotta K, Funahashi T, Bodki N L, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parauel with reduced insulin sensitivity during the progression totype 2 diabetes in rhesus monkeys [J]. Diabetes, 2001, 50: 1126-1133.
[11]Matsubara M, Marucka S, Kataycses. Inverse relationship between plasama adiponectin and leptin concentrations in normal-weight and obese women[J]. European Journal of Endocrinology, 2002, 147(2): 173-180.
[12]Stefan N, Bunt JC, Sallbe AD, et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia [J]. J Clin Endocrinol Metab, 2002, 87(10): 4652-4656.
[13] Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin[J]. Circulation, 1999, 100(25):2473–2476.
[14] Balagopal P, George D, Yarandi H, et al. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents[J]. J Clin Endocrinol Metab, 2005, 90(11): 6192–6197.
[15] Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial [J]. JAMA, 2003, 289(14): 1799–1804.
[16]Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasama lipoproteins [J]. Diabetologia, 2003, 46(4): 459-469.
[17]Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel,adipose-specific protein,adiponectin, in type 2 diabetic patients [J]. Arteriosclerosis Thrombosis, and Vascular biology, 2000, 20(6): 1595-1599.
[18]Huang KC, Chen CL, Chuang LM, et al. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females [J]. J Clin Endocrinol Metab, 2003, 88(9): 4130-4134.
[19]Adamczak M, Wiecek A, Funahashi T, et al. Decreased plasma adiponetin conentration in patients with essential hypertension [J]. Am J Hypertens, 2003, 16(1): 72-75.
[20]Fasshauer M, Klein J, Neumann S, et al. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3-T3-L1 adipocytes[J]. FEBS Lett, 2001, 507(2): 142–146.
[21]Massiera F, Bluch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation [J]. FASEB J, 2001, 15(14): 2727–2729.
[22]李小平,杨成悌,张灵,等.高血压病患者血清脂联素水平的研究[J].中华心血管病杂志, 2004, 32 (7): 596-598.
[23]YANG WS, LEE WJ. Plasma adiponectin levels in overweight and obese Asians [J]. Obesity research, 2002, 10(11): 1104 -1101.
[24] Bluher M, Bullen Jr JW, Lee JH, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training [J]. J Clin Endocrinol Metab, 2006, 91(6): 2310-2316.
[25] Balagopal P, George D, Yarandi H, et al. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents [J] . J Clin Endocrinol Metab, 2005, 90(11): 6192-6197.
[26]Boudou P, Sobngwi E, Mauvais-Jarvis F, et al. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men [J]. Eur J Endocrinol, 2003, 149(5): 421-424.
[27]Soo Lim, Sung Hee Choi, In-Kyong Jeong, et al. Effects of Exercise on Adiponectin and Retinol-Binding Protein-4 Concentrations in Young and Middle-Aged Women [J]. J Clin Endocrinol Metab, 2008, 93(6): 2263-2268.
[28] Ryan AS, Nicklas BJ, Berman DM, et al. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women [J].Int J Obes Relat Metab Sisord JT,2003,27(9):1066-1071.
[29]井源,韩婷,吴静,等.瘦素在糖代谢中的作用及机制[J].国际病理科学与临床杂志, 2007, 27(5): 434-437.
[30]Sinha MK. Human Leptin: the hormone of adipose tissue[J]. Eur J Endocrinol, 1997, 136(5): 461-464.
[31]OSTLUND RE, YANG JIM, KLEIN S, et al. Relation between Plasma Leptin Concentration and Body Fat, Gender, Diet, Age, and Metabolic Covariate [J]. Clin Endo Metab, 1996, 81(11): 3909-3913.
[32]CARO JF, KOLACZYNSKI J W, NYCE M R, et al. Decreased Cerebrospinal Fluid/serum Leptin Ratioin Obesity: a Possible Mechanism for Leptin Resistance [J]. Lancet, 1996, 348(9021): 159-161.
[33]Considine RV, Sinha MK, Heiman ML, et al. Serum Immunoreactive-leptin Concentration in Normal weight and Obese Humans [J]. N Engl J Med, 1996, 334(5): 292-295.
[34]李静宜.瘦素抵抗的研究进展[J].国外医学:遗传学分册, 2003, 26(3): 166-169.
[35]Seufert J, Kiffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implication for the developmeng of adipogenic diabetes [J]. Clin Endocrinol Metab, 1999, 84(2): 670.
[36]Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in a adipose cells:regulation by insulin [J]. J Biol Chem, 1996, 271(5): 2365-2368.
[37]Landt M, Lawson G M, Helgeson J M, et al. Prolonged exercise devreases serum leptin concentrations [J]. Metabolism, 1997, 46(10): 1109-1112.
[38]Torjmail M C, Zafeirdis A, Paolone AM, et al. Serum Leptin During Recovery Following Maximal Incremental and Prolonged Exercise [J]. Sports Med, 1999, 20(7): 444-450.
[39]Essig DA, Alderson NL, Ferguson MA, et al. Delayed Effects of exercise on the plasma leptin concentration [J]. Metabolism, 2000, 49(3): 395-399.
[40]刘迅雷,李骁君,赵兰革,等.非饮食干预条件下耐力运动对单纯性肥胖儿童血压、血脂的影响[J].北京体育大学学报, 2002, 25(2): 198-199.
[41]Cerro AL, Luna PP, Astorga R, et al. Serum leptin levels in male marathon athletes before and after the marathon run[J]. Cline Endocrinol Metal, 1998, 83(7): 2376-2379.
[42]Jung SH, Park HS, Kim KS, et al. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight losss [J]. Journal of Nurtritional Biochemistry, 2008, 19(6): 371-375.
[43]柏建清.有氧运动对大鼠血清瘦素水平(leptin)的影响[J].天津体育学院学报,2008, 23(1): 74-76.
[44]Dirlewanger M, Di Vetta V, Giusti V, et al. Effect of moderate physical activity on plasma leptin concentration in human[J]. Appl Physiology and Occupational Physiology, 1999, 79(4): 331-335.
[45]何玉秀,白文忠,姚玉霞,等.运动对脂肪积累及肥胖基因表达的影响[J].体育科学, 1998, 18(3): 20-24.
[46]张缨.有氧运动训练对大鼠下丘脑食欲调节肽的影响[J].中国运动医学杂志, 2002, 21(1): 19-22.
[47]李翠珍,赵刚.不同游泳时间对高脂膳食大鼠血清瘦素及胰岛素水平的影响[J].中国科技信息, 2009, 24: 200-201.
[48] Pasman WJ, Westerterp-Plantenga MS, Saris WH.The effect of exercise training on leptin,levels in obese males[J]. Am J Physiol, 1998, 274(2): E 280-286.
[49]丛琳,陈吉棣.运动对糖尿病大鼠瘦素受体基因水平与功能的影响[J].体育科学, 2001,21(4): 54-57.
[50]Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes[J]. J Clin Invest, 2005, 115(5): 1111-1119.
[51]Hotamisligil GS. Inflammatory pathways and insulin action[J]. Int J Obesity, 2003, 27(Suppl 3): S53-S55.
[52]Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals[J].Int J Obesity, 2003, 27(Suppl 3): S25-S28.
[53]Nishimura S, Manabe I, Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome[J]. Discov Med, 2009, 8(41): 55-60.
[54]Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue initiation propagation and remodeling[J]. Future Lipidol, 2008, 3(5): 545-556.
[55]Pedersen BK, Bruunsgaard H. Possible beneficial role of exercise in modulating low-grade inflammation in the elderly [J]. Scand J Med Sci Sports, 2003, 13(1): 56- 62.
[56]沈海军,欧红芹,沈捷,等. IL-6在人单核细胞和脂肪细胞共培养体系中水平的相关变化[J].南京医科大学学报, 2010, 30(5): 649-652.
[57]Mohamed-A1i V, Goodriek S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumornecrsis factor-αin vivo[J]. J Clin Endocrinol Metab, 1997, 82(12): 4196-4200.
[58]Jens MB, Camilla V, Toubro S, et al. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α, effect of weight loss in obese men [J]. Eur J Endocrinol, 2003, 148(5): 535-542.
[59]Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome inmorbidly obese patients [J]. Arterioscler Thromb Vasc Biol, 2003, 23(6): 1042-1047.
[60]Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro[J]. J Clin Endocrinol Metab, 2002, 87(5): 2084-2089.
[61]Fernández-Real JM, Broch M, Vendrell J, et al. Interleukin-6 genepolymorphism and lipid abnormalities in healthy subjects[J]. J Clin Endo Meta, 2000, 85(3): 334-339.
[62]Papanicolaou DA , Petrides JS, Tsigos C, et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines[J]. Am J Physiol, 1996,271 (3Pt 1): E601-E605.
[63]Bhagat K, Vallance P. Inflammatory cytokines impair endothelium dependent dilatation in human veins in vivo [J]. Circulation, 1997, 96 (9): 3042-3047.
[64]Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis[J]. Br Heart J, 1993, 69 (1 suppl): S38-41.
[65]高从容,杨凌辉,王奇金,等.单纯性肥胖患者血清IL-6水平的变化及西布曲明减重治疗对其的影响[J].第二军医大学学报, 2004, 25(3): 317-319.
[66]Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid [J]. J Clin EndocrinolMetab, 1998, 83 (3): 847-850.
[67]Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial function in obese women after weight loss over one year [J]. Circulation, 2002, 105 (7): 804-809.
[68]Pedersen BK, Hoffmangoetz L. Exercise and the immune system: regulation, integration, and adaptation[J]. Physiol Rev, 2000, 80(3): 1055-1081.
[69]Febbraiom A, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles[J]. FASEB J, 2002, 16(11): 1335-1347.
[70]Ostrowski K, Rohde T, ASP S, et al. Chemokines are elevated in plasma after strenuous exercise in humans [J]. Eur J App1 Physio, 2001, 84(3): 244-245.
[71]Hulver MW, Houmard JA. Plasma leptin and exercise: recent findings [J]. Sports Med, 2003, 33(7): 473-482.
[72]王朝迅,裴海成,邱明才.运动减重对超重和肥胖者血清TNF-α、IL-6和CRP水平的影响[J].中国医师进修杂志, 2006, 29(10): 26-28.
[73]Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss[J].J Clin Endocrinol Metab, 2000, 85(9): 3338-3342.
[74]Pedersen BK, Bruunsgaard H. Possible beneficial role of exercise in modulating low-grade inflammati on in the elderly[J]. Scand J Med Sci Sports, 2003, 13 (1): 56-62.
[75] Hiroyuki H , Skazuo K. C-reactive protein is all independent predictor of the rate increase in early carotid atherosclerosis[J]. Circulation, 2001, 104 (1): 63-67.
[76]赵小松,朱依纯,姚泰.白细胞与原发性高血压[J].高血压杂志, 1998, 6 (1): 58-60.
[77] Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effects of C-reactive protein on human endothelin cells [J]. Circulation, 2000, 102 (18): 2165-2168.
[78]Moon YS, Ki m DH, Song DK. Serum tumor necrosis fact or alpha levels and components of the metabolic syndrome in obese adolescents[J]. Metabolism, 2004, 53 (7): 863-867.
[79]倪世宁,王大为,顾英霞,刘倩琦,朱子阳,沈金培,等.单纯性肥胖儿童胰岛素抵抗与肿瘤坏死因子-α的关系[J].实用儿科临床杂志, 2006, 21 (8) : 469-470.
[80]颜伟健,吴静,莫娟,等.肥胖儿童血浆脂联素与肿瘤坏死因子-α的变化及意义[J].中国当代儿科杂志.2009,11(1):47-50.
[81]Kern PA, Saghizadeh M, Ong JM et al. The expression of Tumor Necrosis Factor in Human Adipose Tissue: Regulation by Obesity Weight Loss, and Relationship to Lipoprotein Lipase [J]. J Clin Invest, 1995, 95(5): 2111-2119.
[82]Hauner H, Petruschke T, RussM. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia, 1995, 38(7): 764-771.
[83] Medeiros 1M, Reed S, Castelo A, et al. Circulation levels of sTNFR and discrepancy between cytotoxicity and immunorc activity of TNF alpha in patients with visceral leishmaniasis. Clin Micro Boil Infect, 2000, 6(1):34-37.
[84]Hotamisligil GS, Arner P, Atkinson RL, et al. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance [J]. Diabetes, 1997, 46(3): 451-455.
[85]Fernandez-Real JM,Broch M,Rican W,et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance [J]. Diabetes, 1998, 47(11): 1757-1762.
[86]Zahorska-Markiewic B, Janowska J, Olszanccka-Glinianowicz M, et al. Serum concentrations of TNF-αin obesity [J]. J Obes Relat Metab Disord, 2000, 24(11): 1392-1395.
[87] Shing-shin Yeh, Suh-yug Wu, Daniel M Levine, et al.The correlation of cytokine levels with body weight after megestrol acetate treatment in getiatric patients[J].The Journals of Gerontology, 2001, 56A: M48.
[88]Das UN. Is obesity an inflammatory condition [J]? Nutrition, 2001, 17(12): 953-966.
[89]Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition [J]. Diabetologia, 2005, 48(3): 519-528.
[90]O'Brien KD, Brehm BJ, Seeley RJ, et al. Diet induced weight loss is associated with decreases in plasma serum amyloid A and C reactive protein independent of dietary macronut rientcom position in obese subjects [J]. Clin Endocrinol Metab, 2005, 90(4): 2244-2249.
[91]Mohanty P, Aljada A, Ghanim H, et al. Evidence for a potent antiinflammatory effect of rosiglitazone [J]. Clin Endocrinol Metab, 2004, 89(6): 2728-2735.
[92]余舒杰.血清A-SAA与肥胖的关系.新医学, 2006, 37(3): 162-164.
[93]Danesh J, Muir J, Wong YK, et al. Risk factors for coronary heart disease and acute-phase proteins:a population-based study [J]. Eur Heart J, 1999, 20 (13): 954-959.
[94]Yang RZ, Lee MJ, Hu H, et al. Acute phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications[J].PLoS Med, 2006, 3(6): 884-894.
[95]Santos MG, Pegoraro M, Sandrini F, et al. Risk factors for the development of atherosclerosis in childhood and adolescence[J]. Arq Bras Cardiol, 2008, 90(4): 276-283.
[96]刘建凤,白伟,贾丽娟,等.超重肥胖儿童血清淀粉样蛋白A与颈总动脉内中膜厚度相关性研究[J].河北医药, 2010, 32(7): 827-828.
[97]Gómez-Ambrosi J, Azcona C, Patin o-García A, et al. Serum Amyloid A concentration is increased in obese children and adolescents [J]. J Pediatr, 2008, 153(1): 71-75.
[98]Godfrey SG, Catherine A. SAA, HDL biogenesis, and inflammation[J]. J Lipid Res, 2008, 49: 269-270.
[99]Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoproteins cellular affinity. A clue to serum amyloid A'sprincipal function [J]. Lab Invest, 1992, 66(6): 778-785.
[100]Ken O, Shinichi M, Youichiro W, et al. A serum amyloid A and LDL complex as a new prognostic marker instable coronary artery disease[J]. Atherosclerosis, 2004, 174(2): 349-356.
[101]Kazuhiko K, Noriko S, Yasuhisa K, et al. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL is associated with obesity and the metabolic syndrome [J]. Atherosclerosis, 2009, 204(2): 526-531.
[102]陈瞒,余舒杰,赵长林等.中老年人血清淀粉样蛋白水平与体育运动及吸烟的关系.中国临床康复[J]. 2005, 47(9): 14-16.
[103] Rothenbacher D, Hoffmeister A, Brenner H, et al. Physical activity coronary heart disease, and inflammatory response[J]. Arch Itern Med 2003, 163(10): 1200-1205
[104]温先勇,杭永伦,邓辉胜等.氧化应激和炎症反应在冠心病中的作用及其相互关系[J].中国临床康复, 2005, 9(11): 38-39.
[105] Williams PT. High-density lipoprotein cholesterol and other rise factors for coronary heart disease in female runners[J]. N Engl J Med, 1996, 334(20): 1298-1303.
[106]王兵,李毅军.运动对冠心病患者的康复作用[J].中国临床康复, 2003, 7(12): 1843.
[107]Verdaet D, Dendale P, Bacquer DD, et al. Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease[J]. Atherosclerosis, 2004, 176(2): 303-310.
[108]Pitsavos C, Chrysohoou C, Panagiotakos DB, et al. Association of leisure time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloidA, and fibrinogen) in healthy subjects (from the ATTI CA Study)[J]. Am J Cardiol, 2003, 91(1): 368-370.
[109]Julia K, Christian K, Roberts, Tung H, et al. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease[J]. Metabolism, 2004, 53(3): 377-381.
[1]Cooke JP, Tsao PS. Is NO an endogenous antiatherogenic molecule? [J]Arterioscler Thromb, 1994, 14(5): 653-655.
[2]Creager MA, Cooke J P, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans[J]. J Clin Invest, 1990, 86 (1): 228-234.
[3]汪翼,牛峰海,寻文龙,等.单纯性肥胖儿童血管内皮分泌功能和内皮依赖性舒张功能障碍的研究[J].中华儿科杂志, 2000, 38(7): 86-88.
[4]殷松楼,张慧宝.运动对大鼠主动脉损伤后内皮素和一氧化氮合酶的影响[J].中国心血管康复医学, 1997, 6(1-2): 11-16.
[5]唐小梅,孙焱,黄叔怀.不同运动训练对大鼠心血管内分泌功能的影响[J].现代康复, 2001, 5(4): 40-41.
[6]常芸,林福美.不同类型运动心脏的内分泌改变特征[J].中国运动医学杂志, 1996, 15(3): 162.
[7]Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J.The effect of weight loss on serum concentrations of nitric oxide,TNF-αand soluble TNF-αreceptors[J]. Endokrynologia Polska, 2006, 57(5): 487-493.
[8]Kingwell B A, Sherrard B, Jennings G L, et al. Four weeks of cycle training increases basal production of nitric oxide from the forearm [J]. Am J Physiol, 1997, 272(3 Pt 2): H1070-1077.
[9]Asako M, Seiji M, Mutsuko Y, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men[J]. Angiology, 2009, 60(3): 351-357.
[10] Green D, Maiorana A, O’Driscoll G, et al. Effect of Exercise Training in Endothelium-derived Nitric Oxide Function in Humans[J]. J Physiol, 2004, 561 (Pt 1):1-25.
[11]Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability[J]. Circulation, 2002, 106(20): 2530-2532.
[12]Esposito K, Marfalla R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome:a randomized trial [J]. JAMA, 2004, 292(12): 1440-1446.
[13]陈瑶,李倩,汪翼,等.肥胖儿童血浆血管假性血友病因子与动脉粥样硬化指数的相关性分析[J].中国实用儿科杂志, 2006, 21(11): 865-866.
[14]Garanty-Bogacka B, Syrenicz M, Syrenicz A. Serum markers of inflammation and endothelial activati on in children with obesity-related hypertension [J]. Neurol Endocrinol Lett, 2005, 26 (3):242-246.
[15]王振义主编.血栓与止血(基础与临床)[M].上海:科学技术出版社, 1988, 30-264.
[16]李宁川,黄叔怀.运动与血管假血友病因子[J].中国临床康复, 2004, 8(18): 3618-3619.
[17] Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9): 1135-1143.
[18]Witokwska AM. Soluble ICAM-1: A Maker of Vascular inflammation and lifestyle [J]. Cytokine, 2005, 31(2): 127-134.
[19]Gavin J, Paul M. Novel clinical marker of vascular wall inflammation[J]. Circulation research, 2001, 89(9): 763.
[20]Adamopoulos S, Parisis J, Kroupis C, et al. Physical training reduces peripheral marker of inflammation in patients with chronic heart failure [J]. Eur heart J, 2001, 22(9): 791-797.
[21]Glowinska B, Urban M, Peczynska J, et al. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes [J]. Metabolism, 2005, 54 (8): 1020-1026.
[22]Ramírez MM, García MI, Bahri E, et al. Effect of a high glucose load on serum adhesion markers in obese women[J]. Med Clin (Barc), 2009, 132 (11), 407-413.
[23]Marchesi S, Vaudo G, Lupattelli G, et al. Fat distribution and endothelial function in normal-overweight menopausal women[J]. Journal of Clinical Pharmacy and Therapeutics, 2007, 32(5): 477-482.
[24]郭英,王玉,王纯等.亚极量踏车运动对血清sICAM-1表达水平的影响[J].四川体育科学, 2006, 2:22-24.
[25]Nieman DC. Exercise and resistance to infection[J]. Can J Physiol Pharmacol, 1995, 76(5): 573-580.
[26]Nielsen HG., Lyberg T. Long-Distance Running Modulates the Expression of Leucocyte and Endothelial Adhesion Molecules [J]. Scand J Immunol, 2004, 60(4): 356-362.
[27]王金良,谭峰,丁德权等.早期综合康复治疗对急性脑梗死患者运动功能、sICAM-1和IL-6的影响[J].中国医药导报, 2009, 22(2): 27-29.
[28]Mogharnasi M, Gaeini AA, Javadi E, et al. The effect of endurance training on inflammatory biomarkers and lipid profiles in wistar rats[J]. World Journal of Sport Sciences, 2009, 2(2): 82-88.
[29]Yannakoulia M, Chrousos GP, Sidossis LS. Aerobic exercise training improves insulin sentivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls [J]. Metabolism, 2005, 54(11): 1472-1479.
[30]Hammett CJ, Prapavessis H, Baldi JC, et al. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk [J]. American Heart J, 2006, 151(2): 367.e7-367.e16.
[31]Wegge JK, Roberts CK, Ngo TH, et al. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease [J]. Metabolism, 2004, 53(3): 377-381.
[32]尚金华,黄文英.运动抗炎症作用机制研究[J].浙江体育科学, 2008, 30 (6): 97-99.
[33]WEISBERG S P, MCCANN D, DESAI M, et al. Obesity is as sociated with macrophage accumulation in adipose tissue[J]. J Clin Invest, 2003, 112(12): 1796-180.
[34]Giltay EJ, Elbers JM, Gooren LJ, et al. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women modulation by cross-sex hormone administration [J]. Thromb Vasc Biol, 1998, 18(11): 1716-1722.
[35]Dietzmann K, Von BP, Krause D, et al. Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study[J]. Pathol Res Pract, 2000, 196 (1): 15-21.
[36]Cigolini M, Targher G, Bergamo Andreis IA, et al. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men[J].Arterioscler Thromb Vacs Biol, 1996, 16(3): 368-370.
[37]Meilahm EN, Cauley JA, Tracy RP, et al. Association of sex hormones and adiposiry with plasma concentrations of fibrinogen and PAI-1 in postmenopausal women [J]. AMJ Epidemiol, 1996, 143(2): 159-162.
[38]Sawdey MS, Lockutoff DJ. Regulation of murine type I plasminogen activator by inhibitor gene expression in vivo, tissue specificity and induction by lipopolysaccharide tumor necrosis factor alpha and transformin growth factor beta [J]. J Clin Invest, 1991, 88(4): 1346-1348. [ 39 ]Salomaa V, Stinson V, Kark JD. Association of fibrionlytic parameters with early atherosclerosis the ARIC study atherosclerosis risk incommunities study [J]. Circulation, 1995, 91(2): 284-290.
[40]崔克勤,苏胜偶,尹博英,等. 2型糖尿病合并冠心病与血浆纤溶酶原激活物抑制剂-1水平的相关性研[J].临床荟萃, 2006, 21(16): 1150-1152.
[41]陈弹,程绪杰,李红霞,等.肿瘤坏死因子α和血管紧张素Ⅱ对内皮细胞释放PAI-1的影响[J].中国血液流变学杂, 2003, 13(3): 219-224.
[42]Legnani C, Maccaferri M, Tonini P, et al. Reduced fibrinolytic response in obese children: association with high baseline activity of the fast acting plasmino genactivator inhibitor-1(PAI-1) [J]. Fibrinolysis, 1988, 2: 211-213.
[43]El-Sayed MS, Sale C, Jones PG, et al. Blood hemostasis in exercise and training[J]. Med Sci Sports Exerc, 2000, 32(5): 918-925.